PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	micronutrient	CHEBI_EXT	[10]	[23]	BMJ_2008_Nov_7_337_a2001_T0
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	pregnancy	GO_BP_EXT	[47]	[56]	BMJ_2008_Nov_7_337_a2001_T423
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	birth	GO_BP_EXT	[60]	[65]	BMJ_2008_Nov_7_337_a2001_T424
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	gestation	GO_BP_EXT	[86]	[95]	BMJ_2008_Nov_7_337_a2001_T425
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	perinatal	GO_BP_EXT	[101]	[110]	BMJ_2008_Nov_7_337_a2001_T426
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	perinatal	UBERON_EXT	[101]	[110]	BMJ_2008_Nov_7_337_a2001_T847
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	micronutrients	CHEBI_EXT	[279]	[293]	BMJ_2008_Nov_7_337_a2001_T1
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	iron	CHEBI_EXT	[297]	[301]	BMJ_2008_Nov_7_337_a2001_T2
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	folic acid	CHEBI_EXT	[306]	[316]	BMJ_2008_Nov_7_337_a2001_T3
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	folic acid	CHEBI_EXT	[331]	[341]	BMJ_2008_Nov_7_337_a2001_T4
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	birth	GO_BP_EXT	[351]	[356]	BMJ_2008_Nov_7_337_a2001_T427
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	gestation	GO_BP_EXT	[377]	[386]	BMJ_2008_Nov_7_337_a2001_T428
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	haemoglobin	CHEBI_EXT	[401]	[412]	BMJ_2008_Nov_7_337_a2001_T5
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	haemoglobin	CHEBI_EXT	[401]	[412]	BMJ_2008_Nov_7_337_a2001_T750
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_3	[556]	[610]	['Participants 5828 pregnant women and 4697 live births.']	pregnant	GO_BP_EXT	[574]	[582]	BMJ_2008_Nov_7_337_a2001_T429
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_3	[556]	[610]	['Participants 5828 pregnant women and 4697 live births.']	women	NCBITAXON_EXT	[583]	[588]	BMJ_2008_Nov_7_337_a2001_T770
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	pregnant	GO_BP_EXT	[658]	[666]	BMJ_2008_Nov_7_337_a2001_T430
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	women	NCBITAXON_EXT	[667]	[672]	BMJ_2008_Nov_7_337_a2001_T771
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	women	UBERON_EXT	[667]	[672]	BMJ_2008_Nov_7_337_a2001_T848
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	folic acid	CHEBI_EXT	[694]	[704]	BMJ_2008_Nov_7_337_a2001_T6
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	iron	CHEBI_EXT	[716]	[720]	BMJ_2008_Nov_7_337_a2001_T7
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	folic acid	CHEBI_EXT	[726]	[736]	BMJ_2008_Nov_7_337_a2001_T8
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	micronutrients	CHEBI_EXT	[750]	[764]	BMJ_2008_Nov_7_337_a2001_T9
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	vitamins	CHEBI_EXT	[800]	[808]	BMJ_2008_Nov_7_337_a2001_T10
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_4	[611]	[822]	['Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.']	minerals	CHEBI_EXT	[813]	[821]	BMJ_2008_Nov_7_337_a2001_T11
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_5	[823]	[930]	['Main outcome measures Birth weight, length, and head circumference measured within 72 hours after delivery.']	Birth	GO_BP_EXT	[845]	[850]	BMJ_2008_Nov_7_337_a2001_T431
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_5	[823]	[930]	['Main outcome measures Birth weight, length, and head circumference measured within 72 hours after delivery.']	head	UBERON_EXT	[871]	[875]	BMJ_2008_Nov_7_337_a2001_T849
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_5	[823]	[930]	['Main outcome measures Birth weight, length, and head circumference measured within 72 hours after delivery.']	delivery	GO_BP_EXT	[921]	[929]	BMJ_2008_Nov_7_337_a2001_T432
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_6	[931]	[990]	['Neonatal survival assessed at the six week follow-up visit.']	Neonatal	UBERON_EXT	[931]	[939]	BMJ_2008_Nov_7_337_a2001_T850
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_7	[991]	[1136]	['Results Birth weight was 42 g (95% confidence interval 7 to 78 g) higher in the multiple micronutrients group compared with the folic acid group.']	micronutrients	CHEBI_EXT	[1080]	[1094]	BMJ_2008_Nov_7_337_a2001_T12
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_7	[991]	[1136]	['Results Birth weight was 42 g (95% confidence interval 7 to 78 g) higher in the multiple micronutrients group compared with the folic acid group.']	folic acid	CHEBI_EXT	[1119]	[1129]	BMJ_2008_Nov_7_337_a2001_T13
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_8	[1137]	[1311]	['Duration of gestation was 0.23 weeks (0.10 to 0.36 weeks) longer in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks) longer in the multiple micronutrients group.']	gestation	GO_BP_EXT	[1149]	[1158]	BMJ_2008_Nov_7_337_a2001_T433
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_8	[1137]	[1311]	['Duration of gestation was 0.23 weeks (0.10 to 0.36 weeks) longer in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks) longer in the multiple micronutrients group.']	iron	CHEBI_EXT	[1209]	[1213]	BMJ_2008_Nov_7_337_a2001_T14
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_8	[1137]	[1311]	['Duration of gestation was 0.23 weeks (0.10 to 0.36 weeks) longer in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks) longer in the multiple micronutrients group.']	folic acid	CHEBI_EXT	[1214]	[1224]	BMJ_2008_Nov_7_337_a2001_T15
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_8	[1137]	[1311]	['Duration of gestation was 0.23 weeks (0.10 to 0.36 weeks) longer in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks) longer in the multiple micronutrients group.']	micronutrients	CHEBI_EXT	[1290]	[1304]	BMJ_2008_Nov_7_337_a2001_T16
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_9	[1312]	[1459]	['Iron-folic acid was associated with a significantly reduced risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	Iron	CHEBI_EXT	[1312]	[1316]	BMJ_2008_Nov_7_337_a2001_T17
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_9	[1312]	[1459]	['Iron-folic acid was associated with a significantly reduced risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	folic acid	CHEBI_EXT	[1317]	[1327]	BMJ_2008_Nov_7_337_a2001_T18
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_9	[1312]	[1459]	['Iron-folic acid was associated with a significantly reduced risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	delivery	GO_BP_EXT	[1394]	[1402]	BMJ_2008_Nov_7_337_a2001_T434
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_10	[1460]	[1682]	['There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone.']	haemoglobin	CHEBI_EXT	[1496]	[1507]	BMJ_2008_Nov_7_337_a2001_T19
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_10	[1460]	[1682]	['There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone.']	haemoglobin	CHEBI_EXT	[1496]	[1507]	BMJ_2008_Nov_7_337_a2001_T751
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_10	[1460]	[1682]	['There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone.']	iron	CHEBI_EXT	[1530]	[1534]	BMJ_2008_Nov_7_337_a2001_T20
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_10	[1460]	[1682]	['There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone.']	folic acid	CHEBI_EXT	[1535]	[1545]	BMJ_2008_Nov_7_337_a2001_T21
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_10	[1460]	[1682]	['There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone.']	micronutrients	CHEBI_EXT	[1594]	[1608]	BMJ_2008_Nov_7_337_a2001_T22
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_10	[1460]	[1682]	['There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone.']	folic acid	CHEBI_EXT	[1665]	[1675]	BMJ_2008_Nov_7_337_a2001_T23
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	perinatal	GO_BP_EXT	[1746]	[1755]	BMJ_2008_Nov_7_337_a2001_T435
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	perinatal	UBERON_EXT	[1746]	[1755]	BMJ_2008_Nov_7_337_a2001_T851
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	iron	CHEBI_EXT	[1771]	[1775]	BMJ_2008_Nov_7_337_a2001_T24
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	folic acid	CHEBI_EXT	[1776]	[1786]	BMJ_2008_Nov_7_337_a2001_T25
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	neonatal	UBERON_EXT	[1837]	[1845]	BMJ_2008_Nov_7_337_a2001_T852
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_12	[1899]	[2093]	['Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid.']	iron	CHEBI_EXT	[1971]	[1975]	BMJ_2008_Nov_7_337_a2001_T26
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_12	[1899]	[2093]	['Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid.']	folic acid	CHEBI_EXT	[1976]	[1986]	BMJ_2008_Nov_7_337_a2001_T27
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_12	[1899]	[2093]	['Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid.']	gestation	GO_BP_EXT	[2014]	[2023]	BMJ_2008_Nov_7_337_a2001_T436
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_12	[1899]	[2093]	['Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid.']	neonatal	UBERON_EXT	[2049]	[2057]	BMJ_2008_Nov_7_337_a2001_T853
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_12	[1899]	[2093]	['Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid.']	folic acid	CHEBI_EXT	[2082]	[2092]	BMJ_2008_Nov_7_337_a2001_T28
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	micronutrients	CHEBI_EXT	[2103]	[2117]	BMJ_2008_Nov_7_337_a2001_T29
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	birth	GO_BP_EXT	[2158]	[2163]	BMJ_2008_Nov_7_337_a2001_T437
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	folic acid	CHEBI_EXT	[2185]	[2195]	BMJ_2008_Nov_7_337_a2001_T30
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	neonatal	UBERON_EXT	[2272]	[2280]	BMJ_2008_Nov_7_337_a2001_T854
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	women	NCBITAXON_EXT	[2301]	[2306]	BMJ_2008_Nov_7_337_a2001_T772
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	women	UBERON_EXT	[2301]	[2306]	BMJ_2008_Nov_7_337_a2001_T855
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	iron	CHEBI_EXT	[2356]	[2360]	BMJ_2008_Nov_7_337_a2001_T31
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	nutrient	CHEBI_EXT	[2364]	[2372]	BMJ_2008_Nov_7_337_a2001_T32
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	neonatal	UBERON_EXT	[2411]	[2419]	BMJ_2008_Nov_7_337_a2001_T856
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	Neonatal	UBERON_EXT	[2480]	[2488]	BMJ_2008_Nov_7_337_a2001_T857
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	deaths	GO_BP_EXT	[2489]	[2495]	BMJ_2008_Nov_7_337_a2001_T438
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	child	NCBITAXON_EXT	[2518]	[2523]	BMJ_2008_Nov_7_337_a2001_T773
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	child	UBERON_EXT	[2518]	[2523]	BMJ_2008_Nov_7_337_a2001_T858
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	deaths	GO_BP_EXT	[2569]	[2575]	BMJ_2008_Nov_7_337_a2001_T439
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	deaths	GO_BP_EXT	[2623]	[2629]	BMJ_2008_Nov_7_337_a2001_T440
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	children	NCBITAXON_EXT	[2633]	[2641]	BMJ_2008_Nov_7_337_a2001_T774
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	children	UBERON_EXT	[2633]	[2641]	BMJ_2008_Nov_7_337_a2001_T859
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	neonatal	UBERON_EXT	[2681]	[2689]	BMJ_2008_Nov_7_337_a2001_T860
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	deaths	GO_BP_EXT	[2736]	[2742]	BMJ_2008_Nov_7_337_a2001_T441
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	children	NCBITAXON_EXT	[2746]	[2754]	BMJ_2008_Nov_7_337_a2001_T775
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	children	UBERON_EXT	[2746]	[2754]	BMJ_2008_Nov_7_337_a2001_T861
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	babies	UBERON_EXT	[2780]	[2786]	BMJ_2008_Nov_7_337_a2001_T862
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	birth	GO_BP_EXT	[2854]	[2859]	BMJ_2008_Nov_7_337_a2001_T442
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	postnatal	GO_BP_EXT	[2891]	[2900]	BMJ_2008_Nov_7_337_a2001_T443
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	growth	GO_BP_EXT	[2901]	[2907]	BMJ_2008_Nov_7_337_a2001_T444
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	cognitive	GO_BP_EXT	[2983]	[2992]	BMJ_2008_Nov_7_337_a2001_T445
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	birth	GO_BP_EXT	[3038]	[3043]	BMJ_2008_Nov_7_337_a2001_T446
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	pregnancy	GO_BP_EXT	[3138]	[3147]	BMJ_2008_Nov_7_337_a2001_T447
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	growth	GO_BP_EXT	[3179]	[3185]	BMJ_2008_Nov_7_337_a2001_T448
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	nutrient	CHEBI_EXT	[3291]	[3299]	BMJ_2008_Nov_7_337_a2001_T33
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	placental	UBERON_EXT	[3317]	[3326]	BMJ_2008_Nov_7_337_a2001_T863
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	fetal	UBERON_EXT	[3331]	[3336]	BMJ_2008_Nov_7_337_a2001_T864
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	growth	GO_BP_EXT	[3337]	[3343]	BMJ_2008_Nov_7_337_a2001_T449
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	micronutrient	CHEBI_EXT	[3366]	[3379]	BMJ_2008_Nov_7_337_a2001_T34
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	pregnancy	GO_BP_EXT	[3396]	[3405]	BMJ_2008_Nov_7_337_a2001_T450
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	birth	GO_BP_EXT	[3444]	[3449]	BMJ_2008_Nov_7_337_a2001_T451
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	micronutrient	CHEBI_EXT	[3542]	[3555]	BMJ_2008_Nov_7_337_a2001_T35
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	pregnancy	GO_BP_EXT	[3571]	[3580]	BMJ_2008_Nov_7_337_a2001_T452
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	individual	NCBITAXON_EXT	[3610]	[3620]	BMJ_2008_Nov_7_337_a2001_T776
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	pregnant	GO_BP_EXT	[3633]	[3641]	BMJ_2008_Nov_7_337_a2001_T453
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	women	NCBITAXON_EXT	[3642]	[3647]	BMJ_2008_Nov_7_337_a2001_T777
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	women	UBERON_EXT	[3642]	[3647]	BMJ_2008_Nov_7_337_a2001_T865
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	birth	GO_BP_EXT	[3737]	[3742]	BMJ_2008_Nov_7_337_a2001_T454
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_17	[3806]	[4091]	['A 1999 survey of low birth weight in China showed a prevalence of low birth weight of 7.6% and 11.8% in “poor” and “very poor” counties, respectively.10With an average prevalence of low birth weight of 5.9%, an estimated 1.2 million low birthweight babies are born in China every year.']	babies	UBERON_EXT	[4055]	[4061]	BMJ_2008_Nov_7_337_a2001_T866
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_17	[3806]	[4091]	['A 1999 survey of low birth weight in China showed a prevalence of low birth weight of 7.6% and 11.8% in “poor” and “very poor” counties, respectively.10With an average prevalence of low birth weight of 5.9%, an estimated 1.2 million low birthweight babies are born in China every year.']	born	GO_BP_EXT	[4066]	[4070]	BMJ_2008_Nov_7_337_a2001_T455
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	folic acid	CHEBI_EXT	[4169]	[4179]	BMJ_2008_Nov_7_337_a2001_T36
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	neural tube	UBERON_EXT	[4202]	[4213]	BMJ_2008_Nov_7_337_a2001_T867
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	micronutrient	CHEBI_EXT	[4302]	[4315]	BMJ_2008_Nov_7_337_a2001_T37
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	iron	CHEBI_EXT	[4319]	[4323]	BMJ_2008_Nov_7_337_a2001_T38
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	folic acid	CHEBI_EXT	[4324]	[4334]	BMJ_2008_Nov_7_337_a2001_T39
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	pregnancy	GO_BP_EXT	[4354]	[4363]	BMJ_2008_Nov_7_337_a2001_T456
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	women	NCBITAXON_EXT	[4387]	[4392]	BMJ_2008_Nov_7_337_a2001_T778
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	women	UBERON_EXT	[4387]	[4392]	BMJ_2008_Nov_7_337_a2001_T868
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_19	[4394]	[4601]	['To provide evidence in China to formulate public health policy on nutrient supplementation in pregnancy we conducted a community based cluster randomised controlled trial in a disadvantaged rural population.']	nutrient	CHEBI_EXT	[4460]	[4468]	BMJ_2008_Nov_7_337_a2001_T40
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_19	[4394]	[4601]	['To provide evidence in China to formulate public health policy on nutrient supplementation in pregnancy we conducted a community based cluster randomised controlled trial in a disadvantaged rural population.']	pregnancy	GO_BP_EXT	[4488]	[4497]	BMJ_2008_Nov_7_337_a2001_T457
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	iron	CHEBI_EXT	[4628]	[4632]	BMJ_2008_Nov_7_337_a2001_T41
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	folic acid	CHEBI_EXT	[4633]	[4643]	BMJ_2008_Nov_7_337_a2001_T42
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	micronutrient	CHEBI_EXT	[4657]	[4670]	BMJ_2008_Nov_7_337_a2001_T43
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	pregnancy	GO_BP_EXT	[4690]	[4699]	BMJ_2008_Nov_7_337_a2001_T458
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	folic acid	CHEBI_EXT	[4715]	[4725]	BMJ_2008_Nov_7_337_a2001_T44
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	birth	GO_BP_EXT	[4736]	[4741]	BMJ_2008_Nov_7_337_a2001_T459
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	gestation	GO_BP_EXT	[4769]	[4778]	BMJ_2008_Nov_7_337_a2001_T460
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	haemoglobin	CHEBI_EXT	[4793]	[4804]	BMJ_2008_Nov_7_337_a2001_T45
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	haemoglobin	CHEBI_EXT	[4793]	[4804]	BMJ_2008_Nov_7_337_a2001_T752
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	supplements	CHEBI_EXT	[4904]	[4915]	BMJ_2008_Nov_7_337_a2001_T46
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	perinatal	GO_BP_EXT	[4919]	[4928]	BMJ_2008_Nov_7_337_a2001_T461
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	perinatal	UBERON_EXT	[4919]	[4928]	BMJ_2008_Nov_7_337_a2001_T869
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	neonatal	UBERON_EXT	[4973]	[4981]	BMJ_2008_Nov_7_337_a2001_T870
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	deaths	GO_BP_EXT	[4982]	[4988]	BMJ_2008_Nov_7_337_a2001_T462
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	birth	GO_BP_EXT	[5135]	[5140]	BMJ_2008_Nov_7_337_a2001_T463
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	women	NCBITAXON_EXT	[5164]	[5169]	BMJ_2008_Nov_7_337_a2001_T779
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	women	UBERON_EXT	[5164]	[5169]	BMJ_2008_Nov_7_337_a2001_T871
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	haemoglobin	CHEBI_EXT	[5184]	[5195]	BMJ_2008_Nov_7_337_a2001_T47
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	haemoglobin	CHEBI_EXT	[5184]	[5195]	BMJ_2008_Nov_7_337_a2001_T753
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_24	[5230]	[5338]	['Because of the scale of this trial we allocated the same treatment to all pregnant women in a given village.']	pregnant	GO_BP_EXT	[5304]	[5312]	BMJ_2008_Nov_7_337_a2001_T464
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_24	[5230]	[5338]	['Because of the scale of this trial we allocated the same treatment to all pregnant women in a given village.']	women	NCBITAXON_EXT	[5313]	[5318]	BMJ_2008_Nov_7_337_a2001_T780
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_24	[5230]	[5338]	['Because of the scale of this trial we allocated the same treatment to all pregnant women in a given village.']	women	UBERON_EXT	[5313]	[5318]	BMJ_2008_Nov_7_337_a2001_T872
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_26	[5476]	[5686]	['Randomisation of villages was stratified by county with a fixed ratio of treatments (1:1:1) and blocking of 15 to ensure geographical balance with an approximately equal distribution of treatments per township.']	township	UBERON_EXT	[5677]	[5685]	BMJ_2008_Nov_7_337_a2001_T873
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_30	[6049]	[6259]	['Study population and sample size\nThe study sample consisted of all women resident in the counties who became pregnant between August 2002 and January 2006 and who fulfilled trial selection criteria (see below).']	women	NCBITAXON_EXT	[6116]	[6121]	BMJ_2008_Nov_7_337_a2001_T781
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_30	[6049]	[6259]	['Study population and sample size\nThe study sample consisted of all women resident in the counties who became pregnant between August 2002 and January 2006 and who fulfilled trial selection criteria (see below).']	women	UBERON_EXT	[6116]	[6121]	BMJ_2008_Nov_7_337_a2001_T874
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_30	[6049]	[6259]	['Study population and sample size\nThe study sample consisted of all women resident in the counties who became pregnant between August 2002 and January 2006 and who fulfilled trial selection criteria (see below).']	pregnant	GO_BP_EXT	[6158]	[6166]	BMJ_2008_Nov_7_337_a2001_T465
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	pregnant	GO_BP_EXT	[6345]	[6353]	BMJ_2008_Nov_7_337_a2001_T466
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	women	NCBITAXON_EXT	[6354]	[6359]	BMJ_2008_Nov_7_337_a2001_T782
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	women	UBERON_EXT	[6354]	[6359]	BMJ_2008_Nov_7_337_a2001_T875
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	iron	CHEBI_EXT	[6435]	[6439]	BMJ_2008_Nov_7_337_a2001_T48
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	folic acid	CHEBI_EXT	[6440]	[6450]	BMJ_2008_Nov_7_337_a2001_T49
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	micronutrient	CHEBI_EXT	[6463]	[6476]	BMJ_2008_Nov_7_337_a2001_T50
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	folic acid	CHEBI_EXT	[6481]	[6491]	BMJ_2008_Nov_7_337_a2001_T51
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_32	[6699]	[6813]	['We increased the sample size to 2480 pregnant women per group to account for 10% fetal loss and loss to follow-up.']	pregnant	GO_BP_EXT	[6736]	[6744]	BMJ_2008_Nov_7_337_a2001_T467
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_32	[6699]	[6813]	['We increased the sample size to 2480 pregnant women per group to account for 10% fetal loss and loss to follow-up.']	women	NCBITAXON_EXT	[6745]	[6750]	BMJ_2008_Nov_7_337_a2001_T783
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_32	[6699]	[6813]	['We increased the sample size to 2480 pregnant women per group to account for 10% fetal loss and loss to follow-up.']	women	UBERON_EXT	[6745]	[6750]	BMJ_2008_Nov_7_337_a2001_T876
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	births	GO_BP_EXT	[7026]	[7032]	BMJ_2008_Nov_7_337_a2001_T468
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	women	NCBITAXON_EXT	[7041]	[7046]	BMJ_2008_Nov_7_337_a2001_T784
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	women	UBERON_EXT	[7041]	[7046]	BMJ_2008_Nov_7_337_a2001_T877
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	birth	GO_BP_EXT	[7132]	[7137]	BMJ_2008_Nov_7_337_a2001_T469
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	child	NCBITAXON_EXT	[7157]	[7162]	BMJ_2008_Nov_7_337_a2001_T785
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	child	UBERON_EXT	[7157]	[7162]	BMJ_2008_Nov_7_337_a2001_T878
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_36	[7273]	[7354]	['At that stage, January 2006, we had recruited and randomised 5828 eligible women.']	women	NCBITAXON_EXT	[7348]	[7353]	BMJ_2008_Nov_7_337_a2001_T786
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_36	[7273]	[7354]	['At that stage, January 2006, we had recruited and randomised 5828 eligible women.']	women	UBERON_EXT	[7348]	[7353]	BMJ_2008_Nov_7_337_a2001_T879
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	women	NCBITAXON_EXT	[7399]	[7404]	BMJ_2008_Nov_7_337_a2001_T787
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	women	UBERON_EXT	[7399]	[7404]	BMJ_2008_Nov_7_337_a2001_T880
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	birth	GO_BP_EXT	[7474]	[7479]	BMJ_2008_Nov_7_337_a2001_T470
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	iron	CHEBI_EXT	[7502]	[7506]	BMJ_2008_Nov_7_337_a2001_T52
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	acid	CHEBI_EXT	[7513]	[7517]	BMJ_2008_Nov_7_337_a2001_T53
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	micronutrients	CHEBI_EXT	[7530]	[7544]	BMJ_2008_Nov_7_337_a2001_T54
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	folic acid	CHEBI_EXT	[7549]	[7559]	BMJ_2008_Nov_7_337_a2001_T55
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	birth	GO_BP_EXT	[7622]	[7627]	BMJ_2008_Nov_7_337_a2001_T471
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_38	[7724]	[7977]	['This sample size, however, only had 80% power to detect a 40% reduction in low birth weight between treatment groups, assuming a two tailed test, with α=0.05 and a prevalence of low birth weight of 4.6% (prevalence observed across all treatment groups).']	birth	GO_BP_EXT	[7803]	[7808]	BMJ_2008_Nov_7_337_a2001_T472
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_39	[7978]	[8203]	['It also had a similarly low power of 80% to detect a 50% reduction in early neonatal mortality between treatment groups, assuming a two tailed test, with α=0.05 and an early neonatal mortality rate of 15 per 1000 live births.']	neonatal	UBERON_EXT	[8054]	[8062]	BMJ_2008_Nov_7_337_a2001_T881
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_39	[7978]	[8203]	['It also had a similarly low power of 80% to detect a 50% reduction in early neonatal mortality between treatment groups, assuming a two tailed test, with α=0.05 and an early neonatal mortality rate of 15 per 1000 live births.']	neonatal	UBERON_EXT	[8152]	[8160]	BMJ_2008_Nov_7_337_a2001_T882
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	pregnancy surveillance	GO_BP_EXT	[8313]	[8335]	BMJ_2008_Nov_7_337_a2001_T473
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	child	NCBITAXON_EXT	[8408]	[8413]	BMJ_2008_Nov_7_337_a2001_T788
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	child	UBERON_EXT	[8408]	[8413]	BMJ_2008_Nov_7_337_a2001_T883
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	women	NCBITAXON_EXT	[8444]	[8449]	BMJ_2008_Nov_7_337_a2001_T789
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	women	UBERON_EXT	[8444]	[8449]	BMJ_2008_Nov_7_337_a2001_T884
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	pregnancy	GO_BP_EXT	[8477]	[8486]	BMJ_2008_Nov_7_337_a2001_T474
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	women	NCBITAXON_EXT	[8490]	[8495]	BMJ_2008_Nov_7_337_a2001_T790
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_41	[8299]	[8516]	['Enrolment and pregnancy surveillance procedures\nVillage doctors, with support from the township maternal and child healthcare workers, recruited women by active surveillance for pregnancy in women of reproductive age.']	women	UBERON_EXT	[8490]	[8495]	BMJ_2008_Nov_7_337_a2001_T885
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	women	NCBITAXON_EXT	[8580]	[8585]	BMJ_2008_Nov_7_337_a2001_T791
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	women	UBERON_EXT	[8580]	[8585]	BMJ_2008_Nov_7_337_a2001_T886
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	reproductive	GO_BP_EXT	[8589]	[8601]	BMJ_2008_Nov_7_337_a2001_T475
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	pregnant	GO_BP_EXT	[8674]	[8682]	BMJ_2008_Nov_7_337_a2001_T476
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	women	NCBITAXON_EXT	[8708]	[8713]	BMJ_2008_Nov_7_337_a2001_T792
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	child	NCBITAXON_EXT	[8778]	[8783]	BMJ_2008_Nov_7_337_a2001_T793
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	child	UBERON_EXT	[8778]	[8783]	BMJ_2008_Nov_7_337_a2001_T887
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_43	[8785]	[8970]	['Trained village doctors obtained informed verbal consent for pregnancy monitoring, and consenting women were visited every month and asked about the date of their last menstrual period.']	pregnancy	GO_BP_EXT	[8846]	[8855]	BMJ_2008_Nov_7_337_a2001_T477
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_43	[8785]	[8970]	['Trained village doctors obtained informed verbal consent for pregnancy monitoring, and consenting women were visited every month and asked about the date of their last menstrual period.']	women	NCBITAXON_EXT	[8883]	[8888]	BMJ_2008_Nov_7_337_a2001_T794
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_43	[8785]	[8970]	['Trained village doctors obtained informed verbal consent for pregnancy monitoring, and consenting women were visited every month and asked about the date of their last menstrual period.']	women	UBERON_EXT	[8883]	[8888]	BMJ_2008_Nov_7_337_a2001_T888
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_43	[8785]	[8970]	['Trained village doctors obtained informed verbal consent for pregnancy monitoring, and consenting women were visited every month and asked about the date of their last menstrual period.']	menstrual	GO_BP_EXT	[8953]	[8962]	BMJ_2008_Nov_7_337_a2001_T478
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_43	[8785]	[8970]	['Trained village doctors obtained informed verbal consent for pregnancy monitoring, and consenting women were visited every month and asked about the date of their last menstrual period.']	menstrual	UBERON_EXT	[8953]	[8962]	BMJ_2008_Nov_7_337_a2001_T889
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_44	[8971]	[9138]	['Women with periods delayed by more than five days had a urine pregnancy test, and confirmed pregnancies were reported to the township maternal and child health worker.']	Women	NCBITAXON_EXT	[8971]	[8976]	BMJ_2008_Nov_7_337_a2001_T795
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_44	[8971]	[9138]	['Women with periods delayed by more than five days had a urine pregnancy test, and confirmed pregnancies were reported to the township maternal and child health worker.']	urine	UBERON_EXT	[9027]	[9032]	BMJ_2008_Nov_7_337_a2001_T890
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_44	[8971]	[9138]	['Women with periods delayed by more than five days had a urine pregnancy test, and confirmed pregnancies were reported to the township maternal and child health worker.']	pregnancy	GO_BP_EXT	[9033]	[9042]	BMJ_2008_Nov_7_337_a2001_T479
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_44	[8971]	[9138]	['Women with periods delayed by more than five days had a urine pregnancy test, and confirmed pregnancies were reported to the township maternal and child health worker.']	pregnancies	GO_BP_EXT	[9063]	[9074]	BMJ_2008_Nov_7_337_a2001_T480
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_44	[8971]	[9138]	['Women with periods delayed by more than five days had a urine pregnancy test, and confirmed pregnancies were reported to the township maternal and child health worker.']	child	NCBITAXON_EXT	[9118]	[9123]	BMJ_2008_Nov_7_337_a2001_T796
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_44	[8971]	[9138]	['Women with periods delayed by more than five days had a urine pregnancy test, and confirmed pregnancies were reported to the township maternal and child health worker.']	child	UBERON_EXT	[9118]	[9123]	BMJ_2008_Nov_7_337_a2001_T891
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_45	[9139]	[9278]	['Pregnancies in women resident in the studied townships or counties were passively detected at antenatal clinics in local health facilities.']	Pregnancies	GO_BP_EXT	[9139]	[9150]	BMJ_2008_Nov_7_337_a2001_T481
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_45	[9139]	[9278]	['Pregnancies in women resident in the studied townships or counties were passively detected at antenatal clinics in local health facilities.']	women	NCBITAXON_EXT	[9154]	[9159]	BMJ_2008_Nov_7_337_a2001_T797
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_45	[9139]	[9278]	['Pregnancies in women resident in the studied townships or counties were passively detected at antenatal clinics in local health facilities.']	women	UBERON_EXT	[9154]	[9159]	BMJ_2008_Nov_7_337_a2001_T892
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_45	[9139]	[9278]	['Pregnancies in women resident in the studied townships or counties were passively detected at antenatal clinics in local health facilities.']	antenatal	GO_BP_EXT	[9233]	[9242]	BMJ_2008_Nov_7_337_a2001_T482
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_46	[9279]	[9473]	['If the diagnosed pregnancy was less than 28 weeks’ gestation, trained MCH staff from township hospitals sought informed verbal consent to participate in the trial from the woman and her partner.']	pregnancy	GO_BP_EXT	[9296]	[9305]	BMJ_2008_Nov_7_337_a2001_T483
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_46	[9279]	[9473]	['If the diagnosed pregnancy was less than 28 weeks’ gestation, trained MCH staff from township hospitals sought informed verbal consent to participate in the trial from the woman and her partner.']	gestation	GO_BP_EXT	[9330]	[9339]	BMJ_2008_Nov_7_337_a2001_T484
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_46	[9279]	[9473]	['If the diagnosed pregnancy was less than 28 weeks’ gestation, trained MCH staff from township hospitals sought informed verbal consent to participate in the trial from the woman and her partner.']	woman	NCBITAXON_EXT	[9451]	[9456]	BMJ_2008_Nov_7_337_a2001_T798
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_47	[9474]	[9626]	['Newly identified pregnant women were interviewed to record their sociodemographic status and their menstrual, reproductive, medical, and family history.']	pregnant	GO_BP_EXT	[9491]	[9499]	BMJ_2008_Nov_7_337_a2001_T485
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_47	[9474]	[9626]	['Newly identified pregnant women were interviewed to record their sociodemographic status and their menstrual, reproductive, medical, and family history.']	women	NCBITAXON_EXT	[9500]	[9505]	BMJ_2008_Nov_7_337_a2001_T799
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_47	[9474]	[9626]	['Newly identified pregnant women were interviewed to record their sociodemographic status and their menstrual, reproductive, medical, and family history.']	menstrual	GO_BP_EXT	[9573]	[9582]	BMJ_2008_Nov_7_337_a2001_T486
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_47	[9474]	[9626]	['Newly identified pregnant women were interviewed to record their sociodemographic status and their menstrual, reproductive, medical, and family history.']	reproductive	GO_BP_EXT	[9584]	[9596]	BMJ_2008_Nov_7_337_a2001_T487
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_48	[9627]	[9835]	['Recruited pregnant women received three free antenatal care checks, at which they were asked about pregnancy complications and underwent a physical examination including blood pressure and weight measurement.']	women	NCBITAXON_EXT	[9646]	[9651]	BMJ_2008_Nov_7_337_a2001_T800
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_48	[9627]	[9835]	['Recruited pregnant women received three free antenatal care checks, at which they were asked about pregnancy complications and underwent a physical examination including blood pressure and weight measurement.']	antenatal	GO_BP_EXT	[9672]	[9681]	BMJ_2008_Nov_7_337_a2001_T488
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_48	[9627]	[9835]	['Recruited pregnant women received three free antenatal care checks, at which they were asked about pregnancy complications and underwent a physical examination including blood pressure and weight measurement.']	pregnancy	GO_BP_EXT	[9726]	[9735]	BMJ_2008_Nov_7_337_a2001_T489
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_48	[9627]	[9835]	['Recruited pregnant women received three free antenatal care checks, at which they were asked about pregnancy complications and underwent a physical examination including blood pressure and weight measurement.']	blood	UBERON_EXT	[9797]	[9802]	BMJ_2008_Nov_7_337_a2001_T893
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_49	[9836]	[9890]	['Haemoglobin was measured at the third antenatal check.']	Haemoglobin	CHEBI_EXT	[9836]	[9847]	BMJ_2008_Nov_7_337_a2001_T56
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_49	[9836]	[9890]	['Haemoglobin was measured at the third antenatal check.']	Haemoglobin	CHEBI_EXT	[9836]	[9847]	BMJ_2008_Nov_7_337_a2001_T754
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_50	[9891]	[10153]	['Trained MCH staff, with monitoring by project staff, collected and recorded all the information collected during the pregnancy until the six week follow-up visit in a pregnancy care record book, which served both as a clinical record and data capture instrument.']	pregnancy	GO_BP_EXT	[10008]	[10017]	BMJ_2008_Nov_7_337_a2001_T490
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_50	[9891]	[10153]	['Trained MCH staff, with monitoring by project staff, collected and recorded all the information collected during the pregnancy until the six week follow-up visit in a pregnancy care record book, which served both as a clinical record and data capture instrument.']	pregnancy	GO_BP_EXT	[10058]	[10067]	BMJ_2008_Nov_7_337_a2001_T491
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_50	[9891]	[10153]	['Trained MCH staff, with monitoring by project staff, collected and recorded all the information collected during the pregnancy until the six week follow-up visit in a pregnancy care record book, which served both as a clinical record and data capture instrument.']	pregnancy	UBERON_EXT	[10058]	[10067]	BMJ_2008_Nov_7_337_a2001_T894
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	women	NCBITAXON_EXT	[10205]	[10210]	BMJ_2008_Nov_7_337_a2001_T801
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	women	UBERON_EXT	[10205]	[10210]	BMJ_2008_Nov_7_337_a2001_T895
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	antenatal	GO_BP_EXT	[10241]	[10250]	BMJ_2008_Nov_7_337_a2001_T492
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	micronutrients	CHEBI_EXT	[10273]	[10287]	BMJ_2008_Nov_7_337_a2001_T57
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	iron	CHEBI_EXT	[10289]	[10293]	BMJ_2008_Nov_7_337_a2001_T58
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	folic acid	CHEBI_EXT	[10294]	[10304]	BMJ_2008_Nov_7_337_a2001_T59
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_51	[10155]	[10336]	['Interventions\nVillages were randomly assigned for women to receive one of three daily antenatal supplements: multiple micronutrients, iron-folic acid, or folic acid alone (control).']	folic acid	CHEBI_EXT	[10309]	[10319]	BMJ_2008_Nov_7_337_a2001_T60
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	micronutrient	CHEBI_EXT	[10350]	[10363]	BMJ_2008_Nov_7_337_a2001_T61
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	minerals	CHEBI_EXT	[10478]	[10486]	BMJ_2008_Nov_7_337_a2001_T62
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamins	CHEBI_EXT	[10490]	[10498]	BMJ_2008_Nov_7_337_a2001_T63
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	iron	CHEBI_EXT	[10517]	[10521]	BMJ_2008_Nov_7_337_a2001_T64
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	folate	CHEBI_EXT	[10530]	[10536]	BMJ_2008_Nov_7_337_a2001_T65
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	zinc	CHEBI_EXT	[10546]	[10550]	BMJ_2008_Nov_7_337_a2001_T66
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	copper	CHEBI_EXT	[10559]	[10565]	BMJ_2008_Nov_7_337_a2001_T67
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	selenium	CHEBI_EXT	[10575]	[10583]	BMJ_2008_Nov_7_337_a2001_T68
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	iodine	CHEBI_EXT	[10594]	[10600]	BMJ_2008_Nov_7_337_a2001_T69
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin A	CHEBI_EXT	[10611]	[10620]	BMJ_2008_Nov_7_337_a2001_T70
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin B	CHEBI_EXT	[10629]	[10638]	BMJ_2008_Nov_7_337_a2001_T71
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	thiamine	CHEBI_EXT	[10642]	[10650]	BMJ_2008_Nov_7_337_a2001_T72
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin B	CHEBI_EXT	[10660]	[10669]	BMJ_2008_Nov_7_337_a2001_T73
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin B	CHEBI_EXT	[10693]	[10702]	BMJ_2008_Nov_7_337_a2001_T74
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	6	CHEBI_EXT	[10703]	[10704]	BMJ_2008_Nov_7_337_a2001_T75
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin B	CHEBI_EXT	[10713]	[10722]	BMJ_2008_Nov_7_337_a2001_T76
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	12	CHEBI_EXT	[10723]	[10725]	BMJ_2008_Nov_7_337_a2001_T77
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin D	CHEBI_EXT	[10734]	[10743]	BMJ_2008_Nov_7_337_a2001_T78
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin C	CHEBI_EXT	[10753]	[10762]	BMJ_2008_Nov_7_337_a2001_T79
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	vitamin E	CHEBI_EXT	[10772]	[10781]	BMJ_2008_Nov_7_337_a2001_T80
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	folic acid	CHEBI_EXT	[10809]	[10819]	BMJ_2008_Nov_7_337_a2001_T81
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	iron	CHEBI_EXT	[10848]	[10852]	BMJ_2008_Nov_7_337_a2001_T82
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	iron	CHEBI_EXT	[10884]	[10888]	BMJ_2008_Nov_7_337_a2001_T83
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	micronutrients	CHEBI_EXT	[10905]	[10919]	BMJ_2008_Nov_7_337_a2001_T84
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	folic acid	CHEBI_EXT	[10932]	[10942]	BMJ_2008_Nov_7_337_a2001_T85
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_53	[10944]	[11001]	['The folic acid supplement contained 400 µg of folic acid.']	folic acid	CHEBI_EXT	[10948]	[10958]	BMJ_2008_Nov_7_337_a2001_T86
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_53	[10944]	[11001]	['The folic acid supplement contained 400 µg of folic acid.']	folic acid	CHEBI_EXT	[10990]	[11000]	BMJ_2008_Nov_7_337_a2001_T87
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_55	[11160]	[11276]	['At enrolment, each woman received a blister pack containing 15 capsules with instructions to take one capsule daily.']	woman	NCBITAXON_EXT	[11179]	[11184]	BMJ_2008_Nov_7_337_a2001_T802
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_55	[11160]	[11276]	['At enrolment, each woman received a blister pack containing 15 capsules with instructions to take one capsule daily.']	blister	UBERON_EXT	[11196]	[11203]	BMJ_2008_Nov_7_337_a2001_T896
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_56	[11277]	[11442]	['The village doctor visited the women every two weeks to provide more supplements and to retrieve the used blister strips and record the number of remaining capsules.']	women	NCBITAXON_EXT	[11308]	[11313]	BMJ_2008_Nov_7_337_a2001_T803
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_56	[11277]	[11442]	['The village doctor visited the women every two weeks to provide more supplements and to retrieve the used blister strips and record the number of remaining capsules.']	women	UBERON_EXT	[11308]	[11313]	BMJ_2008_Nov_7_337_a2001_T897
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_56	[11277]	[11442]	['The village doctor visited the women every two weeks to provide more supplements and to retrieve the used blister strips and record the number of remaining capsules.']	blister	UBERON_EXT	[11383]	[11390]	BMJ_2008_Nov_7_337_a2001_T898
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_57	[11443]	[11533]	['The number of supplements consumed throughout the trial was summed to estimate compliance.']	supplements	CHEBI_EXT	[11457]	[11468]	BMJ_2008_Nov_7_337_a2001_T88
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_58	[11535]	[11632]	['Measurement of outcomes\nHospital nursing staff measured birth weight within one hour of delivery.']	birth	GO_BP_EXT	[11591]	[11596]	BMJ_2008_Nov_7_337_a2001_T493
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_58	[11535]	[11632]	['Measurement of outcomes\nHospital nursing staff measured birth weight within one hour of delivery.']	delivery	GO_BP_EXT	[11623]	[11631]	BMJ_2008_Nov_7_337_a2001_T494
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	birth	GO_BP_EXT	[11710]	[11715]	BMJ_2008_Nov_7_337_a2001_T495
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	birth	GO_BP_EXT	[11725]	[11730]	BMJ_2008_Nov_7_337_a2001_T496
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	births	GO_BP_EXT	[11875]	[11881]	BMJ_2008_Nov_7_337_a2001_T497
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	township	UBERON_EXT	[11900]	[11908]	BMJ_2008_Nov_7_337_a2001_T899
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	birth	GO_BP_EXT	[11927]	[11932]	BMJ_2008_Nov_7_337_a2001_T498
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	births	GO_BP_EXT	[11955]	[11961]	BMJ_2008_Nov_7_337_a2001_T499
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	birth	GO_BP_EXT	[11970]	[11975]	BMJ_2008_Nov_7_337_a2001_T500
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	birth	GO_BP_EXT	[11985]	[11990]	BMJ_2008_Nov_7_337_a2001_T501
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	baby	UBERON_EXT	[12018]	[12022]	BMJ_2008_Nov_7_337_a2001_T900
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	deliveries	GO_BP_EXT	[12127]	[12137]	BMJ_2008_Nov_7_337_a2001_T502
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	child	NCBITAXON_EXT	[12161]	[12166]	BMJ_2008_Nov_7_337_a2001_T804
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	child	UBERON_EXT	[12161]	[12166]	BMJ_2008_Nov_7_337_a2001_T901
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	women	NCBITAXON_EXT	[12192]	[12197]	BMJ_2008_Nov_7_337_a2001_T805
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	delivery	GO_BP_EXT	[12225]	[12233]	BMJ_2008_Nov_7_337_a2001_T503
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	baby	UBERON_EXT	[12249]	[12253]	BMJ_2008_Nov_7_337_a2001_T902
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_59	[11633]	[12289]	['In the six county hospitals and the three largest township hospitals (78% of birth weights) birth weight was measured with an electronic scale (type BD 585, Tanita, Dongguan, Guangdong Province, China) with precision to the nearest 10 g. For births in the 31 smaller township hospitals (10% of birth weights) and for home births (12% of birth weights) birth weight was measured with a baby scale (type RTZ-10A-RT, Wuxi Weigher Factory, Wuxi, China) with precision to the nearest 50 g. For home deliveries, township maternal and child health staff visited the women at home within 72 hours of delivery to measure the baby and gather information on delivery.']	delivery	GO_BP_EXT	[12280]	[12288]	BMJ_2008_Nov_7_337_a2001_T504
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_60	[12290]	[12380]	['We excluded from analyses newborn anthropometry collected later than 72 hours after birth.']	newborn	UBERON_EXT	[12316]	[12323]	BMJ_2008_Nov_7_337_a2001_T903
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_60	[12290]	[12380]	['We excluded from analyses newborn anthropometry collected later than 72 hours after birth.']	birth	GO_BP_EXT	[12374]	[12379]	BMJ_2008_Nov_7_337_a2001_T505
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_61	[12381]	[12526]	['Low birth weight was defined as <2500 g. Birth length was measured to the nearest 1 mm by using a portable measuring board with fixed head piece.']	birth	GO_BP_EXT	[12385]	[12390]	BMJ_2008_Nov_7_337_a2001_T506
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_61	[12381]	[12526]	['Low birth weight was defined as <2500 g. Birth length was measured to the nearest 1 mm by using a portable measuring board with fixed head piece.']	Birth	GO_BP_EXT	[12422]	[12427]	BMJ_2008_Nov_7_337_a2001_T507
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_61	[12381]	[12526]	['Low birth weight was defined as <2500 g. Birth length was measured to the nearest 1 mm by using a portable measuring board with fixed head piece.']	head	UBERON_EXT	[12515]	[12519]	BMJ_2008_Nov_7_337_a2001_T904
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_62	[12527]	[12607]	['Occipitofrontal head circumference was measured with a tape to the nearest 1 mm.']	Occipitofrontal	UBERON_EXT	[12527]	[12542]	BMJ_2008_Nov_7_337_a2001_T905
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_62	[12527]	[12607]	['Occipitofrontal head circumference was measured with a tape to the nearest 1 mm.']	head	UBERON_EXT	[12543]	[12547]	BMJ_2008_Nov_7_337_a2001_T906
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_63	[12608]	[12752]	['Gestational age at birth was measured as completed days based on the first day of the last menstrual period, obtained at the baseline interview.']	Gestational	GO_BP_EXT	[12608]	[12619]	BMJ_2008_Nov_7_337_a2001_T508
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_63	[12608]	[12752]	['Gestational age at birth was measured as completed days based on the first day of the last menstrual period, obtained at the baseline interview.']	birth	GO_BP_EXT	[12627]	[12632]	BMJ_2008_Nov_7_337_a2001_T509
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_63	[12608]	[12752]	['Gestational age at birth was measured as completed days based on the first day of the last menstrual period, obtained at the baseline interview.']	menstrual	GO_BP_EXT	[12699]	[12708]	BMJ_2008_Nov_7_337_a2001_T510
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_63	[12608]	[12752]	['Gestational age at birth was measured as completed days based on the first day of the last menstrual period, obtained at the baseline interview.']	menstrual period	UBERON_EXT	[12699]	[12715]	BMJ_2008_Nov_7_337_a2001_T907
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_64	[12753]	[12877]	['Preterm delivery was defined as delivery before 37 completed weeks’ gestation and early preterm delivery as before 34 weeks.']	delivery	GO_BP_EXT	[12761]	[12769]	BMJ_2008_Nov_7_337_a2001_T511
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_64	[12753]	[12877]	['Preterm delivery was defined as delivery before 37 completed weeks’ gestation and early preterm delivery as before 34 weeks.']	delivery	GO_BP_EXT	[12785]	[12793]	BMJ_2008_Nov_7_337_a2001_T512
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_64	[12753]	[12877]	['Preterm delivery was defined as delivery before 37 completed weeks’ gestation and early preterm delivery as before 34 weeks.']	gestation	GO_BP_EXT	[12821]	[12830]	BMJ_2008_Nov_7_337_a2001_T513
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_64	[12753]	[12877]	['Preterm delivery was defined as delivery before 37 completed weeks’ gestation and early preterm delivery as before 34 weeks.']	delivery	GO_BP_EXT	[12849]	[12857]	BMJ_2008_Nov_7_337_a2001_T514
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	gestational	GO_BP_EXT	[12888]	[12899]	BMJ_2008_Nov_7_337_a2001_T515
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	babies	UBERON_EXT	[12904]	[12910]	BMJ_2008_Nov_7_337_a2001_T908
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	gestational	GO_BP_EXT	[12980]	[12991]	BMJ_2008_Nov_7_337_a2001_T516
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	growth	GO_BP_EXT	[13032]	[13038]	BMJ_2008_Nov_7_337_a2001_T517
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	haemoglobin	CHEBI_EXT	[13051]	[13062]	BMJ_2008_Nov_7_337_a2001_T89
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	haemoglobin	CHEBI_EXT	[13051]	[13062]	BMJ_2008_Nov_7_337_a2001_T755
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	blood	UBERON_EXT	[13103]	[13108]	BMJ_2008_Nov_7_337_a2001_T909
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	gestation	GO_BP_EXT	[13149]	[13158]	BMJ_2008_Nov_7_337_a2001_T518
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	pregnant	GO_BP_EXT	[13196]	[13204]	BMJ_2008_Nov_7_337_a2001_T519
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	women	NCBITAXON_EXT	[13205]	[13210]	BMJ_2008_Nov_7_337_a2001_T806
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_65	[12878]	[13301]	['Small for gestational age babies were defined as those whose weight was below the 10th centile of the gestational age-sex specific US reference for fetal growth.13\nMaternal haemoglobin concentration was measured in capillary blood collected early in the third trimester (gestation 28-32 weeks) from a subsample of 599 pregnant women with a birth outcome, who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	birth	GO_BP_EXT	[13218]	[13223]	BMJ_2008_Nov_7_337_a2001_T520
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_66	[13302]	[13524]	['HemoCue portable spectrophotometers (Ängelholm, Sweden) were used to assay haemoglobin concentration and were calibrated daily and all measurements were made within the temperature operating range of this device (15-30°C).']	haemoglobin	CHEBI_EXT	[13377]	[13388]	BMJ_2008_Nov_7_337_a2001_T90
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_66	[13302]	[13524]	['HemoCue portable spectrophotometers (Ängelholm, Sweden) were used to assay haemoglobin concentration and were calibrated daily and all measurements were made within the temperature operating range of this device (15-30°C).']	haemoglobin	CHEBI_EXT	[13377]	[13388]	BMJ_2008_Nov_7_337_a2001_T756
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_67	[13525]	[13708]	['We excluded haemoglobin measurements collected before 6 July 2004 because in winter these measurements were taken below the operating range, potentially resulting in incorrect values.']	haemoglobin	CHEBI_EXT	[13537]	[13548]	BMJ_2008_Nov_7_337_a2001_T91
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_67	[13525]	[13708]	['We excluded haemoglobin measurements collected before 6 July 2004 because in winter these measurements were taken below the operating range, potentially resulting in incorrect values.']	haemoglobin	CHEBI_EXT	[13537]	[13548]	BMJ_2008_Nov_7_337_a2001_T757
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	haemoglobin	CHEBI_EXT	[13755]	[13766]	BMJ_2008_Nov_7_337_a2001_T92
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	haemoglobin	CHEBI_EXT	[13755]	[13766]	BMJ_2008_Nov_7_337_a2001_T758
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	pregnancy	GO_BP_EXT	[13842]	[13851]	BMJ_2008_Nov_7_337_a2001_T521
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	birth	GO_BP_EXT	[13853]	[13858]	BMJ_2008_Nov_7_337_a2001_T522
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	delivery	GO_BP_EXT	[13868]	[13876]	BMJ_2008_Nov_7_337_a2001_T523
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	neonatal	UBERON_EXT	[13894]	[13902]	BMJ_2008_Nov_7_337_a2001_T910
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	deaths	GO_BP_EXT	[13916]	[13922]	BMJ_2008_Nov_7_337_a2001_T524
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	child	NCBITAXON_EXT	[13937]	[13942]	BMJ_2008_Nov_7_337_a2001_T807
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_68	[13709]	[14001]	['Anaemia in the third trimester was defined as haemoglobin <110 g/l.14\nVillage doctors or hospital staff reported fetal losses during pregnancy, birth outcome, delivery information, and neonatal and maternal deaths; maternal and child health staff recorded data with precoded structured forms.']	child	UBERON_EXT	[13937]	[13942]	BMJ_2008_Nov_7_337_a2001_T911
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_69	[14002]	[14065]	['Neonatal survival was assessed at the six week follow-up visit.']	Neonatal	UBERON_EXT	[14002]	[14010]	BMJ_2008_Nov_7_337_a2001_T912
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	perinatal	GO_BP_EXT	[14077]	[14086]	BMJ_2008_Nov_7_337_a2001_T525
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	perinatal	UBERON_EXT	[14077]	[14086]	BMJ_2008_Nov_7_337_a2001_T913
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	deaths	GO_BP_EXT	[14087]	[14093]	BMJ_2008_Nov_7_337_a2001_T526
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	delivered	GO_BP_EXT	[14118]	[14127]	BMJ_2008_Nov_7_337_a2001_T527
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	gestation	GO_BP_EXT	[14141]	[14150]	BMJ_2008_Nov_7_337_a2001_T528
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	life	UBERON_EXT	[14177]	[14181]	BMJ_2008_Nov_7_337_a2001_T914
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	labour	GO_BP_EXT	[14238]	[14244]	BMJ_2008_Nov_7_337_a2001_T529
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	neonatal	UBERON_EXT	[14257]	[14265]	BMJ_2008_Nov_7_337_a2001_T915
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	deaths	GO_BP_EXT	[14266]	[14272]	BMJ_2008_Nov_7_337_a2001_T530
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	deaths	GO_BP_EXT	[14274]	[14280]	BMJ_2008_Nov_7_337_a2001_T531
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	infants	UBERON_EXT	[14296]	[14303]	BMJ_2008_Nov_7_337_a2001_T916
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_70	[14066]	[14345]	['We defined perinatal deaths as stillbirths (fetuses delivered at 28 weeks’ gestation or later with no signs of life and recorded as occurring before the onset of or during labour) plus early neonatal deaths (deaths among liveborn infants occurring within seven days of delivery).']	delivery	GO_BP_EXT	[14335]	[14343]	BMJ_2008_Nov_7_337_a2001_T532
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_71	[14346]	[14445]	['Neonatal deaths were defined as deaths among liveborn infants occurring within 28 days of delivery.']	Neonatal	UBERON_EXT	[14346]	[14354]	BMJ_2008_Nov_7_337_a2001_T917
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_71	[14346]	[14445]	['Neonatal deaths were defined as deaths among liveborn infants occurring within 28 days of delivery.']	deaths	GO_BP_EXT	[14355]	[14361]	BMJ_2008_Nov_7_337_a2001_T533
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_71	[14346]	[14445]	['Neonatal deaths were defined as deaths among liveborn infants occurring within 28 days of delivery.']	deaths	GO_BP_EXT	[14378]	[14384]	BMJ_2008_Nov_7_337_a2001_T534
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_71	[14346]	[14445]	['Neonatal deaths were defined as deaths among liveborn infants occurring within 28 days of delivery.']	infants	UBERON_EXT	[14400]	[14407]	BMJ_2008_Nov_7_337_a2001_T918
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_71	[14346]	[14445]	['Neonatal deaths were defined as deaths among liveborn infants occurring within 28 days of delivery.']	delivery	GO_BP_EXT	[14436]	[14444]	BMJ_2008_Nov_7_337_a2001_T535
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_72	[14446]	[14634]	['Project staff re-interviewed all women who had a stillbirth or neonatal death to check the reported information and, for hospital or clinic deliveries, to cross check with medical records.']	women	NCBITAXON_EXT	[14479]	[14484]	BMJ_2008_Nov_7_337_a2001_T808
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_72	[14446]	[14634]	['Project staff re-interviewed all women who had a stillbirth or neonatal death to check the reported information and, for hospital or clinic deliveries, to cross check with medical records.']	women	UBERON_EXT	[14479]	[14484]	BMJ_2008_Nov_7_337_a2001_T919
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_72	[14446]	[14634]	['Project staff re-interviewed all women who had a stillbirth or neonatal death to check the reported information and, for hospital or clinic deliveries, to cross check with medical records.']	stillbirth	GO_BP_EXT	[14495]	[14505]	BMJ_2008_Nov_7_337_a2001_T536
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_72	[14446]	[14634]	['Project staff re-interviewed all women who had a stillbirth or neonatal death to check the reported information and, for hospital or clinic deliveries, to cross check with medical records.']	neonatal	UBERON_EXT	[14509]	[14517]	BMJ_2008_Nov_7_337_a2001_T920
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_72	[14446]	[14634]	['Project staff re-interviewed all women who had a stillbirth or neonatal death to check the reported information and, for hospital or clinic deliveries, to cross check with medical records.']	death	GO_BP_EXT	[14518]	[14523]	BMJ_2008_Nov_7_337_a2001_T537
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_72	[14446]	[14634]	['Project staff re-interviewed all women who had a stillbirth or neonatal death to check the reported information and, for hospital or clinic deliveries, to cross check with medical records.']	deliveries	GO_BP_EXT	[14586]	[14596]	BMJ_2008_Nov_7_337_a2001_T538
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_73	[14636]	[14817]	['Statistical analysis\nTo assess the effectiveness of randomisation we examined the baseline characteristics of the clusters and the individual pregnant women across treatment groups.']	pregnant	GO_BP_EXT	[14778]	[14786]	BMJ_2008_Nov_7_337_a2001_T539
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_73	[14636]	[14817]	['Statistical analysis\nTo assess the effectiveness of randomisation we examined the baseline characteristics of the clusters and the individual pregnant women across treatment groups.']	women	NCBITAXON_EXT	[14787]	[14792]	BMJ_2008_Nov_7_337_a2001_T809
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_73	[14636]	[14817]	['Statistical analysis\nTo assess the effectiveness of randomisation we examined the baseline characteristics of the clusters and the individual pregnant women across treatment groups.']	women	UBERON_EXT	[14787]	[14792]	BMJ_2008_Nov_7_337_a2001_T921
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_75	[15064]	[15206]	['The mean number of supplements consumed and treatment compliance rates (percentage of days that supplements were consumed) were also examined.']	supplements	CHEBI_EXT	[15083]	[15094]	BMJ_2008_Nov_7_337_a2001_T93
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_75	[15064]	[15206]	['The mean number of supplements consumed and treatment compliance rates (percentage of days that supplements were consumed) were also examined.']	consumed	GO_BP_EXT	[15095]	[15103]	BMJ_2008_Nov_7_337_a2001_T540
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_75	[15064]	[15206]	['The mean number of supplements consumed and treatment compliance rates (percentage of days that supplements were consumed) were also examined.']	supplements	CHEBI_EXT	[15160]	[15171]	BMJ_2008_Nov_7_337_a2001_T94
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_75	[15064]	[15206]	['The mean number of supplements consumed and treatment compliance rates (percentage of days that supplements were consumed) were also examined.']	consumed	GO_BP_EXT	[15177]	[15185]	BMJ_2008_Nov_7_337_a2001_T541
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_77	[15275]	[15397]	['We included only liveborn infants in the analyses of birth anthropometry because most stillborn infants were not measured.']	infants	UBERON_EXT	[15301]	[15308]	BMJ_2008_Nov_7_337_a2001_T922
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_77	[15275]	[15397]	['We included only liveborn infants in the analyses of birth anthropometry because most stillborn infants were not measured.']	birth	GO_BP_EXT	[15328]	[15333]	BMJ_2008_Nov_7_337_a2001_T542
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_77	[15275]	[15397]	['We included only liveborn infants in the analyses of birth anthropometry because most stillborn infants were not measured.']	infants	UBERON_EXT	[15371]	[15378]	BMJ_2008_Nov_7_337_a2001_T923
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	birth	GO_BP_EXT	[15461]	[15466]	BMJ_2008_Nov_7_337_a2001_T543
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	gestation	GO_BP_EXT	[15478]	[15487]	BMJ_2008_Nov_7_337_a2001_T544
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	birth	GO_BP_EXT	[15774]	[15779]	BMJ_2008_Nov_7_337_a2001_T545
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	birth	GO_BP_EXT	[15788]	[15793]	BMJ_2008_Nov_7_337_a2001_T546
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	head	UBERON_EXT	[15802]	[15806]	BMJ_2008_Nov_7_337_a2001_T924
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	gestation	GO_BP_EXT	[15826]	[15835]	BMJ_2008_Nov_7_337_a2001_T547
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_78	[15398]	[15920]	['We estimated mean differences and 95% confidence intervals for birth weight and gestation and adjusted for the effect of randomisation by villages using generalised estimating equation linear models with an independent correlation structure, which is a suitable modelling strategy where there are more than 40 clusters per treatment group.1617The adjusted mean differences in birth weight, birth length, head circumference, and gestation, and their 95% confidence intervals, were computed relative to the folic acid group.']	folic acid	CHEBI_EXT	[15903]	[15913]	BMJ_2008_Nov_7_337_a2001_T95
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_79	[15921]	[16125]	['Similarly, we calculated adjusted mean differences for newborn anthropometry and gestation at birth and their 95% confidence intervals to compare the multiple micronutrient and the iron-folic acid groups.']	newborn	UBERON_EXT	[15976]	[15983]	BMJ_2008_Nov_7_337_a2001_T925
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_79	[15921]	[16125]	['Similarly, we calculated adjusted mean differences for newborn anthropometry and gestation at birth and their 95% confidence intervals to compare the multiple micronutrient and the iron-folic acid groups.']	gestation	GO_BP_EXT	[16002]	[16011]	BMJ_2008_Nov_7_337_a2001_T548
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_79	[15921]	[16125]	['Similarly, we calculated adjusted mean differences for newborn anthropometry and gestation at birth and their 95% confidence intervals to compare the multiple micronutrient and the iron-folic acid groups.']	birth	GO_BP_EXT	[16015]	[16020]	BMJ_2008_Nov_7_337_a2001_T549
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_79	[15921]	[16125]	['Similarly, we calculated adjusted mean differences for newborn anthropometry and gestation at birth and their 95% confidence intervals to compare the multiple micronutrient and the iron-folic acid groups.']	micronutrient	CHEBI_EXT	[16080]	[16093]	BMJ_2008_Nov_7_337_a2001_T96
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_79	[15921]	[16125]	['Similarly, we calculated adjusted mean differences for newborn anthropometry and gestation at birth and their 95% confidence intervals to compare the multiple micronutrient and the iron-folic acid groups.']	iron	CHEBI_EXT	[16102]	[16106]	BMJ_2008_Nov_7_337_a2001_T97
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_79	[15921]	[16125]	['Similarly, we calculated adjusted mean differences for newborn anthropometry and gestation at birth and their 95% confidence intervals to compare the multiple micronutrient and the iron-folic acid groups.']	acid groups	CHEBI_EXT	[16113]	[16124]	BMJ_2008_Nov_7_337_a2001_T98
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	birth	GO_BP_EXT	[16355]	[16360]	BMJ_2008_Nov_7_337_a2001_T550
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	gestational	GO_BP_EXT	[16379]	[16390]	BMJ_2008_Nov_7_337_a2001_T551
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	delivery	GO_BP_EXT	[16404]	[16412]	BMJ_2008_Nov_7_337_a2001_T552
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	folic acid	CHEBI_EXT	[16435]	[16445]	BMJ_2008_Nov_7_337_a2001_T99
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	birth	GO_BP_EXT	[16487]	[16492]	BMJ_2008_Nov_7_337_a2001_T553
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	cofactor	CHEBI_EXT	[16508]	[16516]	BMJ_2008_Nov_7_337_a2001_T100
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	micronutrient	CHEBI_EXT	[16556]	[16569]	BMJ_2008_Nov_7_337_a2001_T101
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	iron	CHEBI_EXT	[16574]	[16578]	BMJ_2008_Nov_7_337_a2001_T102
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_80	[16126]	[16597]	['To adjust for cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for low birth weight, small for gestational age, preterm delivery, and anaemia with the folic acid group as the reference and with multiple birth indicator as a cofactor, and similarly to compare the multiple micronutrient and iron-folic acid groups.']	folic acid groups	CHEBI_EXT	[16579]	[16596]	BMJ_2008_Nov_7_337_a2001_T103
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_81	[16598]	[16740]	['We analysed perinatal mortality only in singleton births to prevent bias from the effect of multiple births, which have higher mortality risk.']	perinatal	GO_BP_EXT	[16610]	[16619]	BMJ_2008_Nov_7_337_a2001_T554
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_81	[16598]	[16740]	['We analysed perinatal mortality only in singleton births to prevent bias from the effect of multiple births, which have higher mortality risk.']	perinatal	UBERON_EXT	[16610]	[16619]	BMJ_2008_Nov_7_337_a2001_T926
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_82	[16741]	[16869]	['We calculated rates of stillbirth and perinatal death using the number of pregnancies at 28 weeks’ gestation as the denominator.']	perinatal	GO_BP_EXT	[16779]	[16788]	BMJ_2008_Nov_7_337_a2001_T555
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_82	[16741]	[16869]	['We calculated rates of stillbirth and perinatal death using the number of pregnancies at 28 weeks’ gestation as the denominator.']	perinatal	UBERON_EXT	[16779]	[16788]	BMJ_2008_Nov_7_337_a2001_T927
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_82	[16741]	[16869]	['We calculated rates of stillbirth and perinatal death using the number of pregnancies at 28 weeks’ gestation as the denominator.']	death	GO_BP_EXT	[16789]	[16794]	BMJ_2008_Nov_7_337_a2001_T556
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_82	[16741]	[16869]	['We calculated rates of stillbirth and perinatal death using the number of pregnancies at 28 weeks’ gestation as the denominator.']	pregnancies	GO_BP_EXT	[16815]	[16826]	BMJ_2008_Nov_7_337_a2001_T557
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_82	[16741]	[16869]	['We calculated rates of stillbirth and perinatal death using the number of pregnancies at 28 weeks’ gestation as the denominator.']	gestation	GO_BP_EXT	[16840]	[16849]	BMJ_2008_Nov_7_337_a2001_T558
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_83	[16870]	[16957]	['Neonatal death rates were calculated with the number of live births as the denominator.']	Neonatal	UBERON_EXT	[16870]	[16878]	BMJ_2008_Nov_7_337_a2001_T928
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_83	[16870]	[16957]	['Neonatal death rates were calculated with the number of live births as the denominator.']	death	GO_BP_EXT	[16879]	[16884]	BMJ_2008_Nov_7_337_a2001_T559
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_84	[16958]	[17137]	['Kaplan-Meier survival analysis was used to estimate the survival probabilities of liveborn singleton infants from birth to 28 days and to compare survival across treatment groups.']	infants	UBERON_EXT	[17059]	[17066]	BMJ_2008_Nov_7_337_a2001_T929
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_84	[16958]	[17137]	['Kaplan-Meier survival analysis was used to estimate the survival probabilities of liveborn singleton infants from birth to 28 days and to compare survival across treatment groups.']	birth	GO_BP_EXT	[17072]	[17077]	BMJ_2008_Nov_7_337_a2001_T560
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_85	[17138]	[17460]	['To adjust for the cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for stillbirth and perinatal and neonatal death rates with the folic acid group as the reference.']	stillbirth	GO_BP_EXT	[17367]	[17377]	BMJ_2008_Nov_7_337_a2001_T561
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_85	[17138]	[17460]	['To adjust for the cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for stillbirth and perinatal and neonatal death rates with the folic acid group as the reference.']	perinatal	UBERON_EXT	[17382]	[17391]	BMJ_2008_Nov_7_337_a2001_T930
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_85	[17138]	[17460]	['To adjust for the cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for stillbirth and perinatal and neonatal death rates with the folic acid group as the reference.']	perinatal ...	GO_BP_EXT	[17382]	[17391]	BMJ_2008_Nov_7_337_a2001_T562
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_85	[17138]	[17460]	['To adjust for the cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for stillbirth and perinatal and neonatal death rates with the folic acid group as the reference.']	neonatal	UBERON_EXT	[17396]	[17404]	BMJ_2008_Nov_7_337_a2001_T931
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_85	[17138]	[17460]	['To adjust for the cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for stillbirth and perinatal and neonatal death rates with the folic acid group as the reference.']	death	GO_BP_EXT	[17405]	[17410]	BMJ_2008_Nov_7_337_a2001_T563
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_85	[17138]	[17460]	['To adjust for the cluster randomisation, we applied generalised estimating equation binomial regression models with log link and exchangeable correlation structures to estimate the relative risks and 95% confidence intervals for stillbirth and perinatal and neonatal death rates with the folic acid group as the reference.']	folic acid	CHEBI_EXT	[17426]	[17436]	BMJ_2008_Nov_7_337_a2001_T104
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_89	[17702]	[17888]	['Enrolment began on 1 August 2002 and continued until 9 July 2005; the last baby born to a trial participant was on 24 January 2006, and all women completed the trial by 28 February 2006.']	baby	UBERON_EXT	[17777]	[17781]	BMJ_2008_Nov_7_337_a2001_T932
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_89	[17702]	[17888]	['Enrolment began on 1 August 2002 and continued until 9 July 2005; the last baby born to a trial participant was on 24 January 2006, and all women completed the trial by 28 February 2006.']	born	GO_BP_EXT	[17782]	[17786]	BMJ_2008_Nov_7_337_a2001_T564
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_89	[17702]	[17888]	['Enrolment began on 1 August 2002 and continued until 9 July 2005; the last baby born to a trial participant was on 24 January 2006, and all women completed the trial by 28 February 2006.']	women	NCBITAXON_EXT	[17842]	[17847]	BMJ_2008_Nov_7_337_a2001_T810
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_90	[17889]	[18125]	['Over the 3.5 year period, there were 7144 confirmed pregnancies from the monitored population: 727 women refused to participate in the trial, 498 did not meet the inclusion criteria, and 91 did not participate for other reasons (fig 1).']	pregnancies	GO_BP_EXT	[17941]	[17952]	BMJ_2008_Nov_7_337_a2001_T565
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_90	[17889]	[18125]	['Over the 3.5 year period, there were 7144 confirmed pregnancies from the monitored population: 727 women refused to participate in the trial, 498 did not meet the inclusion criteria, and 91 did not participate for other reasons (fig 1).']	women	NCBITAXON_EXT	[17988]	[17993]	BMJ_2008_Nov_7_337_a2001_T811
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_90	[17889]	[18125]	['Over the 3.5 year period, there were 7144 confirmed pregnancies from the monitored population: 727 women refused to participate in the trial, 498 did not meet the inclusion criteria, and 91 did not participate for other reasons (fig 1).']	women	UBERON_EXT	[17988]	[17993]	BMJ_2008_Nov_7_337_a2001_T933
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_91	[18126]	[18380]	['We enrolled and randomised 5828 women, but of these 133 women were lost to follow up, 279 stopped taking supplements and refused to continue to participate, and 601 had a spontaneous or induced abortion or other medical condition resulting in fetal loss.']	women	NCBITAXON_EXT	[18158]	[18163]	BMJ_2008_Nov_7_337_a2001_T812
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_91	[18126]	[18380]	['We enrolled and randomised 5828 women, but of these 133 women were lost to follow up, 279 stopped taking supplements and refused to continue to participate, and 601 had a spontaneous or induced abortion or other medical condition resulting in fetal loss.']	women	UBERON_EXT	[18158]	[18163]	BMJ_2008_Nov_7_337_a2001_T934
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_91	[18126]	[18380]	['We enrolled and randomised 5828 women, but of these 133 women were lost to follow up, 279 stopped taking supplements and refused to continue to participate, and 601 had a spontaneous or induced abortion or other medical condition resulting in fetal loss.']	women	NCBITAXON_EXT	[18182]	[18187]	BMJ_2008_Nov_7_337_a2001_T813
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_91	[18126]	[18380]	['We enrolled and randomised 5828 women, but of these 133 women were lost to follow up, 279 stopped taking supplements and refused to continue to participate, and 601 had a spontaneous or induced abortion or other medical condition resulting in fetal loss.']	women	UBERON_EXT	[18182]	[18187]	BMJ_2008_Nov_7_337_a2001_T935
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_91	[18126]	[18380]	['We enrolled and randomised 5828 women, but of these 133 women were lost to follow up, 279 stopped taking supplements and refused to continue to participate, and 601 had a spontaneous or induced abortion or other medical condition resulting in fetal loss.']	supplements	CHEBI_EXT	[18231]	[18242]	BMJ_2008_Nov_7_337_a2001_T105
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_92	[18381]	[18461]	['There were a total of 4650 pregnancies that resulted in at least one live birth.']	pregnancies	GO_BP_EXT	[18408]	[18419]	BMJ_2008_Nov_7_337_a2001_T566
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_92	[18381]	[18461]	['There were a total of 4650 pregnancies that resulted in at least one live birth.']	birth	GO_BP_EXT	[18455]	[18460]	BMJ_2008_Nov_7_337_a2001_T567
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_93	[18462]	[18534]	['There were 167 stillbirths, where birth weight was not usually recorded.']	stillbirths	GO_BP_EXT	[18477]	[18488]	BMJ_2008_Nov_7_337_a2001_T568
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_93	[18462]	[18534]	['There were 167 stillbirths, where birth weight was not usually recorded.']	birth	GO_BP_EXT	[18496]	[18501]	BMJ_2008_Nov_7_337_a2001_T569
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_94	[18535]	[18651]	['There were a total of 4697 live births; birth weight was missing or was measured beyond 72 hours after birth in 276.']	birth	GO_BP_EXT	[18575]	[18580]	BMJ_2008_Nov_7_337_a2001_T570
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_94	[18535]	[18651]	['There were a total of 4697 live births; birth weight was missing or was measured beyond 72 hours after birth in 276.']	birth	GO_BP_EXT	[18638]	[18643]	BMJ_2008_Nov_7_337_a2001_T571
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_95	[18652]	[18752]	['There were 4421 (94%) live births with birth weight available for analysis and 222 perinatal deaths.']	birth	GO_BP_EXT	[18691]	[18696]	BMJ_2008_Nov_7_337_a2001_T572
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_95	[18652]	[18752]	['There were 4421 (94%) live births with birth weight available for analysis and 222 perinatal deaths.']	perinatal	GO_BP_EXT	[18735]	[18744]	BMJ_2008_Nov_7_337_a2001_T573
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_95	[18652]	[18752]	['There were 4421 (94%) live births with birth weight available for analysis and 222 perinatal deaths.']	perinatal	UBERON_EXT	[18735]	[18744]	BMJ_2008_Nov_7_337_a2001_T936
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_95	[18652]	[18752]	['There were 4421 (94%) live births with birth weight available for analysis and 222 perinatal deaths.']	deaths	GO_BP_EXT	[18745]	[18751]	BMJ_2008_Nov_7_337_a2001_T574
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_97	[18891]	[19050]	['Across all treatment groups, 7% of the women were enrolled in a village other than their usual place of residence, and this was usually their mother’s village.']	women	NCBITAXON_EXT	[18930]	[18935]	BMJ_2008_Nov_7_337_a2001_T814
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_97	[18891]	[19050]	['Across all treatment groups, 7% of the women were enrolled in a village other than their usual place of residence, and this was usually their mother’s village.']	women	UBERON_EXT	[18930]	[18935]	BMJ_2008_Nov_7_337_a2001_T937
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	reproductive	GO_BP_EXT	[19292]	[19304]	BMJ_2008_Nov_7_337_a2001_T575
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	pregnant	GO_BP_EXT	[19320]	[19328]	BMJ_2008_Nov_7_337_a2001_T576
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	women	NCBITAXON_EXT	[19329]	[19334]	BMJ_2008_Nov_7_337_a2001_T815
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	women	UBERON_EXT	[19329]	[19334]	BMJ_2008_Nov_7_337_a2001_T938
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	child	UBERON_EXT	[19388]	[19393]	BMJ_2008_Nov_7_337_a2001_T939
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	women	NCBITAXON_EXT	[19421]	[19426]	BMJ_2008_Nov_7_337_a2001_T816
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	pregnancy	GO_BP_EXT	[19446]	[19455]	BMJ_2008_Nov_7_337_a2001_T577
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	women	NCBITAXON_EXT	[19484]	[19489]	BMJ_2008_Nov_7_337_a2001_T817
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	women	UBERON_EXT	[19484]	[19489]	BMJ_2008_Nov_7_337_a2001_T940
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	delivering	GO_BP_EXT	[19490]	[19500]	BMJ_2008_Nov_7_337_a2001_T578
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	iron	CHEBI_EXT	[19566]	[19570]	BMJ_2008_Nov_7_337_a2001_T106
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	folic acid	CHEBI_EXT	[19571]	[19581]	BMJ_2008_Nov_7_337_a2001_T107
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	micronutrients	CHEBI_EXT	[19618]	[19632]	BMJ_2008_Nov_7_337_a2001_T108
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	folic acid	CHEBI_EXT	[19664]	[19674]	BMJ_2008_Nov_7_337_a2001_T109
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_100	[19741]	[20049]	['These multiple births were not balanced across the treatment groups, with 19 pairs of twins (of 1584 births) in the iron-folic acid group, 12 pairs of twins and one set of triplets (of 1558 births) in the multiple micronutrient group, and 17 pairs of twins (of 1722 births) in the folic acid group (P=0.031).']	iron	CHEBI_EXT	[19857]	[19861]	BMJ_2008_Nov_7_337_a2001_T110
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_100	[19741]	[20049]	['These multiple births were not balanced across the treatment groups, with 19 pairs of twins (of 1584 births) in the iron-folic acid group, 12 pairs of twins and one set of triplets (of 1558 births) in the multiple micronutrient group, and 17 pairs of twins (of 1722 births) in the folic acid group (P=0.031).']	folic acid	CHEBI_EXT	[19862]	[19872]	BMJ_2008_Nov_7_337_a2001_T111
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_100	[19741]	[20049]	['These multiple births were not balanced across the treatment groups, with 19 pairs of twins (of 1584 births) in the iron-folic acid group, 12 pairs of twins and one set of triplets (of 1558 births) in the multiple micronutrient group, and 17 pairs of twins (of 1722 births) in the folic acid group (P=0.031).']	micronutrient	CHEBI_EXT	[19955]	[19968]	BMJ_2008_Nov_7_337_a2001_T112
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_100	[19741]	[20049]	['These multiple births were not balanced across the treatment groups, with 19 pairs of twins (of 1584 births) in the iron-folic acid group, 12 pairs of twins and one set of triplets (of 1558 births) in the multiple micronutrient group, and 17 pairs of twins (of 1722 births) in the folic acid group (P=0.031).']	folic acid	CHEBI_EXT	[20022]	[20032]	BMJ_2008_Nov_7_337_a2001_T113
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	acidIron	CHEBI_EXT	[20233]	[20241]	BMJ_2008_Nov_7_337_a2001_T114
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	folic acidMultiple	CHEBI_EXT	[20242]	[20260]	BMJ_2008_Nov_7_337_a2001_T115
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	micronutrientsNo	CHEBI_EXT	[20261]	[20277]	BMJ_2008_Nov_7_337_a2001_T116
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	pregnancies	GO_BP_EXT	[20438]	[20449]	BMJ_2008_Nov_7_337_a2001_T579
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	Women	NCBITAXON_EXT	[20786]	[20791]	BMJ_2008_Nov_7_337_a2001_T818
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	Women	UBERON_EXT	[20786]	[20791]	BMJ_2008_Nov_7_337_a2001_T941
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	Women	NCBITAXON_EXT	[20972]	[20977]	BMJ_2008_Nov_7_337_a2001_T819
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	Women	UBERON_EXT	[20972]	[20977]	BMJ_2008_Nov_7_337_a2001_T942
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	WRAP	PR_EXT	[21283]	[21287]	BMJ_2008_Nov_7_337_a2001_T846
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_102	[20170]	[21378]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of clusters178183170Mean (SD) population in clusters in 2001826 (502)781 (434)890 (515)Mean (SD) births in clusters in 20016.8 (5.4)6.5 (4.4)7.6 (8.6)Mean (SD) pregnancies/cluster/year6.3 (1.1)6.3 (1.1)6.0 (1.3)Mean (SD) No of family members/cluster4.2 (0.77)4.2 (0.81)4.2 (0.89)Maternal age (years):Mean (SD)24.8 (4.4)24.8 (4.3)24.8 (4.4)\u200315-19152 (7.5)153 (8.0)160 (8.4)\u200320-24950 (47.1)875 (45.8)867 (45.7)\u200325-29564 (28.0)567 (29.7)555 (29.2)\u200330-34312 (15.5)277 (14.5)276 (14.5)\u2003≥3539 (1.9)40 (2.1)41 (2.2)Women’s education:\u2003<3 years133 (6.6)100 (5.3)118 (6.2)\u2003Primary527 (26.3)495 (26.0)542 (28.6)\u2003Secondary1087 (54.2)1022 (53.7)962 (50.8)\u2003High school and above259 (12.9)288 (15.1)271 (14.3)Women’s occupation:\u2003Farmer1677 (83.9)1563 (82.3)1599 (84.8)\u2003Other322 (16.1)337 (17.7)287 (15.2)Household wealth index:\u2003Mean (SD)−0.03 (1.49)0.07 (1.53)−0.03 (1.55)\u2003Poorest third665 (33.0)600 (31.4)671 (35.3)\u2003Middle third725 (35.9)639 (33.4)627 (33.0)\u2003Richest third627 (31.1)673 (35.2)601 (31.7)\n\nCaption (TABLE-WRAP): TABLE 2\n\n\u2002Baseline characteristics at enrolment related to pregnancy by treatment group.']	pregnancy	GO_BP_EXT	[21349]	[21358]	BMJ_2008_Nov_7_337_a2001_T580
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	acidIron	CHEBI_EXT	[21442]	[21450]	BMJ_2008_Nov_7_337_a2001_T117
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	folic acidMultiple	CHEBI_EXT	[21451]	[21469]	BMJ_2008_Nov_7_337_a2001_T118
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	micronutrientsNo	CHEBI_EXT	[21470]	[21486]	BMJ_2008_Nov_7_337_a2001_T119
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	pregnant	GO_BP_EXT	[21490]	[21498]	BMJ_2008_Nov_7_337_a2001_T581
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	pregnancies1	GO_BP_EXT	[21532]	[21544]	BMJ_2008_Nov_7_337_a2001_T582
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	Gestation	GO_BP_EXT	[21671]	[21680]	BMJ_2008_Nov_7_337_a2001_T583
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	women199818971878	NCBITAXON_EXT	[21854]	[21871]	BMJ_2008_Nov_7_337_a2001_T820
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	women197018641846	NCBITAXON_EXT	[21933]	[21950]	BMJ_2008_Nov_7_337_a2001_T821
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	women196818631840	NCBITAXON_EXT	[22009]	[22026]	BMJ_2008_Nov_7_337_a2001_T822
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	arm	UBERON_EXT	[22076]	[22079]	BMJ_2008_Nov_7_337_a2001_T943
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	women198318841872	NCBITAXON_EXT	[22106]	[22123]	BMJ_2008_Nov_7_337_a2001_T823
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	women	NCBITAXON_EXT	[22313]	[22318]	BMJ_2008_Nov_7_337_a2001_T824
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	women	UBERON_EXT	[22313]	[22318]	BMJ_2008_Nov_7_337_a2001_T944
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	pregnancy	GO_BP_EXT	[22326]	[22335]	BMJ_2008_Nov_7_337_a2001_T584
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_104	[22381]	[22504]	['About 6% of women consumed fewer than 90 supplements during the pregnancy, and over 80% consumed more than 120 supplements.']	women	NCBITAXON_EXT	[22393]	[22398]	BMJ_2008_Nov_7_337_a2001_T825
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_104	[22381]	[22504]	['About 6% of women consumed fewer than 90 supplements during the pregnancy, and over 80% consumed more than 120 supplements.']	supplements	CHEBI_EXT	[22422]	[22433]	BMJ_2008_Nov_7_337_a2001_T120
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_104	[22381]	[22504]	['About 6% of women consumed fewer than 90 supplements during the pregnancy, and over 80% consumed more than 120 supplements.']	pregnancy	GO_BP_EXT	[22445]	[22454]	BMJ_2008_Nov_7_337_a2001_T585
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_104	[22381]	[22504]	['About 6% of women consumed fewer than 90 supplements during the pregnancy, and over 80% consumed more than 120 supplements.']	supplements	CHEBI_EXT	[22492]	[22503]	BMJ_2008_Nov_7_337_a2001_T121
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	consumed	GO_BP_EXT	[22585]	[22593]	BMJ_2008_Nov_7_337_a2001_T586
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	acidIron	CHEBI_EXT	[22618]	[22626]	BMJ_2008_Nov_7_337_a2001_T122
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	folic acidMultiple	CHEBI_EXT	[22627]	[22645]	BMJ_2008_Nov_7_337_a2001_T123
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	micronutrientsNo	CHEBI_EXT	[22646]	[22662]	BMJ_2008_Nov_7_337_a2001_T124
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	gave	GO_BP_EXT	[22667]	[22671]	BMJ_2008_Nov_7_337_a2001_T587
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	birth170515651545No	GO_BP_EXT	[22672]	[22691]	BMJ_2008_Nov_7_337_a2001_T588
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	consumed	GO_BP_EXT	[22903]	[22911]	BMJ_2008_Nov_7_337_a2001_T589
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	supplements	CHEBI_EXT	[23130]	[23141]	BMJ_2008_Nov_7_337_a2001_T125
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	consumed	GO_BP_EXT	[23142]	[23150]	BMJ_2008_Nov_7_337_a2001_T590
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_105	[22506]	[23208]	['Caption (TABLE-WRAP): TABLE 3 \n\nCompliance* and number of doses of supplements consumed by treatment groupFolic acidIron-folic acidMultiple micronutrientsNo who gave birth170515651545No (%) who complied:\u20030-259 (0.6)16 (1.0)18 (1.2)\u200326-5024 (1.4)29 (1.9)32 (2.1)\u200351-7595 (5.6)110 (7.0)88 (5.7)\u200376-1001577 (92.5)1410 (90.1)1407 (91.1)\u2003Mean (SD)93.4 (12.7)91.9 (14.8)92.6 (14.9)No (%) of supplements consumed:\u2003<90105 (6.2)85 (5.4)106 (6.9)\u200391-119181 (10.6)160 (10.2)154 (10.0)\u2003120-179684 (40.1)638 (40.8)630 (40.8)\u2003≥180735 (43.1)682 (43.6)655 (42.4)\u2003Mean (SD)165 (44)166 (44)165 (45)\n*Compliance calculated by number of actual supplements consumed divided by number of supplements expected to be consumed.']	consumed	GO_BP_EXT	[23199]	[23207]	BMJ_2008_Nov_7_337_a2001_T591
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_106	[23210]	[23393]	['Impact of nutrient supplementation on anthropometry and gestation at birth\nThe intracluster correlation coefficient for birth weight was 0.03 (95% confidence interval 0.015 to 0.052).']	nutrient	CHEBI_EXT	[23220]	[23228]	BMJ_2008_Nov_7_337_a2001_T126
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_106	[23210]	[23393]	['Impact of nutrient supplementation on anthropometry and gestation at birth\nThe intracluster correlation coefficient for birth weight was 0.03 (95% confidence interval 0.015 to 0.052).']	gestation	GO_BP_EXT	[23266]	[23275]	BMJ_2008_Nov_7_337_a2001_T592
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_106	[23210]	[23393]	['Impact of nutrient supplementation on anthropometry and gestation at birth\nThe intracluster correlation coefficient for birth weight was 0.03 (95% confidence interval 0.015 to 0.052).']	birth	GO_BP_EXT	[23279]	[23284]	BMJ_2008_Nov_7_337_a2001_T593
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_106	[23210]	[23393]	['Impact of nutrient supplementation on anthropometry and gestation at birth\nThe intracluster correlation coefficient for birth weight was 0.03 (95% confidence interval 0.015 to 0.052).']	birth	GO_BP_EXT	[23330]	[23335]	BMJ_2008_Nov_7_337_a2001_T594
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	iron	CHEBI_EXT	[23432]	[23436]	BMJ_2008_Nov_7_337_a2001_T127
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	folic acid	CHEBI_EXT	[23437]	[23447]	BMJ_2008_Nov_7_337_a2001_T128
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	birth	GO_BP_EXT	[23456]	[23461]	BMJ_2008_Nov_7_337_a2001_T595
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	birth	GO_BP_EXT	[23482]	[23487]	BMJ_2008_Nov_7_337_a2001_T596
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	micronutrients	CHEBI_EXT	[23563]	[23577]	BMJ_2008_Nov_7_337_a2001_T129
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	folic acid	CHEBI_EXT	[23602]	[23612]	BMJ_2008_Nov_7_337_a2001_T130
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	birth	GO_BP_EXT	[23645]	[23650]	BMJ_2008_Nov_7_337_a2001_T597
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	iron	CHEBI_EXT	[23674]	[23678]	BMJ_2008_Nov_7_337_a2001_T131
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	folic acid	CHEBI_EXT	[23679]	[23689]	BMJ_2008_Nov_7_337_a2001_T132
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	micronutrient	CHEBI_EXT	[23707]	[23720]	BMJ_2008_Nov_7_337_a2001_T133
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	birth	GO_BP_EXT	[23776]	[23781]	BMJ_2008_Nov_7_337_a2001_T598
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	folic acid	CHEBI_EXT	[23813]	[23823]	BMJ_2008_Nov_7_337_a2001_T134
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_108	[23878]	[24127]	['In a post-hoc analysis of babies who were small for gestational age, there were no significant differences in the proportion across the three treatment groups, although the proportion in the multiple micronutrient group was slightly lower (table 4).']	babies	UBERON_EXT	[23904]	[23910]	BMJ_2008_Nov_7_337_a2001_T945
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_108	[23878]	[24127]	['In a post-hoc analysis of babies who were small for gestational age, there were no significant differences in the proportion across the three treatment groups, although the proportion in the multiple micronutrient group was slightly lower (table 4).']	gestational	GO_BP_EXT	[23930]	[23941]	BMJ_2008_Nov_7_337_a2001_T599
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_108	[23878]	[24127]	['In a post-hoc analysis of babies who were small for gestational age, there were no significant differences in the proportion across the three treatment groups, although the proportion in the multiple micronutrient group was slightly lower (table 4).']	micronutrient	CHEBI_EXT	[24078]	[24091]	BMJ_2008_Nov_7_337_a2001_T135
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Birth	GO_BP_EXT	[24161]	[24166]	BMJ_2008_Nov_7_337_a2001_T600
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	gestation	GO_BP_EXT	[24182]	[24191]	BMJ_2008_Nov_7_337_a2001_T601
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	haemoglobin	CHEBI_EXT	[24197]	[24208]	BMJ_2008_Nov_7_337_a2001_T136
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	haemoglobin	CHEBI_EXT	[24197]	[24208]	BMJ_2008_Nov_7_337_a2001_T759
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients	CHEBI_EXT	[24279]	[24293]	BMJ_2008_Nov_7_337_a2001_T137
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	iron	CHEBI_EXT	[24297]	[24301]	BMJ_2008_Nov_7_337_a2001_T138
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid	CHEBI_EXT	[24302]	[24312]	BMJ_2008_Nov_7_337_a2001_T139
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid	CHEBI_EXT	[24318]	[24328]	BMJ_2008_Nov_7_337_a2001_T140
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	infantsMean	UBERON_EXT	[24359]	[24370]	BMJ_2008_Nov_7_337_a2001_T946
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid15453153	CHEBI_EXT	[24447]	[24465]	BMJ_2008_Nov_7_337_a2001_T141
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[24475]	[24479]	BMJ_2008_Nov_7_337_a2001_T142
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid14703173	CHEBI_EXT	[24480]	[24498]	BMJ_2008_Nov_7_337_a2001_T143
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients14063197	CHEBI_EXT	[24542]	[24564]	BMJ_2008_Nov_7_337_a2001_T144
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid82	CHEBI_EXT	[24619]	[24631]	BMJ_2008_Nov_7_337_a2001_T145
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[24638]	[24642]	BMJ_2008_Nov_7_337_a2001_T146
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid66	CHEBI_EXT	[24643]	[24655]	BMJ_2008_Nov_7_337_a2001_T147
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients57	CHEBI_EXT	[24695]	[24711]	BMJ_2008_Nov_7_337_a2001_T148
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	gestational	GO_BP_EXT	[24753]	[24764]	BMJ_2008_Nov_7_337_a2001_T602
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid280	CHEBI_EXT	[24769]	[24782]	BMJ_2008_Nov_7_337_a2001_T149
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[24790]	[24794]	BMJ_2008_Nov_7_337_a2001_T150
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid278	CHEBI_EXT	[24795]	[24808]	BMJ_2008_Nov_7_337_a2001_T151
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients238	CHEBI_EXT	[24849]	[24866]	BMJ_2008_Nov_7_337_a2001_T152
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Gestation	GO_BP_EXT	[24899]	[24908]	BMJ_2008_Nov_7_337_a2001_T603
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	birth	GO_BP_EXT	[24912]	[24917]	BMJ_2008_Nov_7_337_a2001_T604
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid166639	CHEBI_EXT	[24926]	[24942]	BMJ_2008_Nov_7_337_a2001_T153
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[24952]	[24956]	BMJ_2008_Nov_7_337_a2001_T154
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid153739	CHEBI_EXT	[24957]	[24973]	BMJ_2008_Nov_7_337_a2001_T155
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients149439	CHEBI_EXT	[25016]	[25036]	BMJ_2008_Nov_7_337_a2001_T156
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid102	CHEBI_EXT	[25089]	[25102]	BMJ_2008_Nov_7_337_a2001_T157
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[25109]	[25113]	BMJ_2008_Nov_7_337_a2001_T158
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid76	CHEBI_EXT	[25114]	[25126]	BMJ_2008_Nov_7_337_a2001_T159
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients78	CHEBI_EXT	[25166]	[25182]	BMJ_2008_Nov_7_337_a2001_T160
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid30	CHEBI_EXT	[25238]	[25250]	BMJ_2008_Nov_7_337_a2001_T161
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[25258]	[25262]	BMJ_2008_Nov_7_337_a2001_T162
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid15	CHEBI_EXT	[25263]	[25275]	BMJ_2008_Nov_7_337_a2001_T163
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients19	CHEBI_EXT	[25316]	[25332]	BMJ_2008_Nov_7_337_a2001_T164
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Birth	GO_BP_EXT	[25365]	[25370]	BMJ_2008_Nov_7_337_a2001_T605
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid136748	CHEBI_EXT	[25384]	[25400]	BMJ_2008_Nov_7_337_a2001_T165
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[25408]	[25412]	BMJ_2008_Nov_7_337_a2001_T166
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid129949	CHEBI_EXT	[25413]	[25429]	BMJ_2008_Nov_7_337_a2001_T167
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients125149	CHEBI_EXT	[25470]	[25490]	BMJ_2008_Nov_7_337_a2001_T168
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Head	UBERON_EXT	[25524]	[25528]	BMJ_2008_Nov_7_337_a2001_T947
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid135033	CHEBI_EXT	[25549]	[25565]	BMJ_2008_Nov_7_337_a2001_T169
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[25573]	[25577]	BMJ_2008_Nov_7_337_a2001_T170
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid127833	CHEBI_EXT	[25578]	[25594]	BMJ_2008_Nov_7_337_a2001_T171
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients123433	CHEBI_EXT	[25636]	[25656]	BMJ_2008_Nov_7_337_a2001_T172
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Haemoglobin	CHEBI_EXT	[25688]	[25699]	BMJ_2008_Nov_7_337_a2001_T173
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Haemoglobin	CHEBI_EXT	[25688]	[25699]	BMJ_2008_Nov_7_337_a2001_T760
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid218105	CHEBI_EXT	[25708]	[25724]	BMJ_2008_Nov_7_337_a2001_T174
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[25733]	[25737]	BMJ_2008_Nov_7_337_a2001_T175
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid193110	CHEBI_EXT	[25738]	[25754]	BMJ_2008_Nov_7_337_a2001_T176
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients188111	CHEBI_EXT	[25793]	[25813]	BMJ_2008_Nov_7_337_a2001_T177
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Folic acid133	CHEBI_EXT	[25865]	[25878]	BMJ_2008_Nov_7_337_a2001_T178
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	Iron	CHEBI_EXT	[25886]	[25890]	BMJ_2008_Nov_7_337_a2001_T179
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	folic acid87	CHEBI_EXT	[25891]	[25903]	BMJ_2008_Nov_7_337_a2001_T180
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_109	[24129]	[26008]	['Caption (TABLE-WRAP): TABLE 4\n\n\u2002Birth anthropometry, gestation, and haemoglobin, with adjusted difference or relative risk for comparison of multiple micronutrients or iron-folic acid with folic acid aloneBirth outcomesNo (%*) of infantsMean (SD)Adjusted† difference or relative risk (95% CI)P value Birth weight (g)‡ Folic acid15453153.7 (444.9)Iron-folic acid14703173.9 (424.4)24.3 (−10.3 to 59.0)0.169Multiple micronutrients14063197.9 (438.0)42.3 (7.1 to 77.5)0.019 Birth weight <2500 g Folic acid82 (5.3)—Iron-folic acid66 (4.5)—0.81 (0.59 to 1.12)0.199Multiple micronutrients57 (4.1)—0.78 (0.56 to 1.08)0.139 Small for gestational age Folic acid280 (18.1)—Iron-folic acid278 (18.9)—1.04 (0.89 to 1.22)0.618Multiple micronutrients238 (16.9)—0.95 (0.82 to 1.12)0.549 Gestation at birth (weeks) Folic acid166639.63 (1.93)Iron-folic acid153739.84 (1.69)0.23 (0.10 to 0.36)0.001Multiple micronutrients149439.82 (1.80)0.19 (0.06 to 0.32)0.004 Preterm <37 weeks Folic acid102 (6.1)—Iron/folic acid76 (4.9)—0.79 (0.58 to 1.07)0.131Multiple micronutrients78 (5.2)—0.86 (0.64 to 1.14)0.285 Early preterm <34 weeks Folic acid30 (1.80)—Iron-folic acid15 (0.98)—0.50 (0.27 to 0.94)0.031Multiple micronutrients19 (1.27)—0.70 (0.38 to 1.30)0.259 Birth length (cm)§ Folic acid136748.8 (2.9)Iron-folic acid129949.1 (2.7)0.24 (0.02 to 0.46)0.032Multiple micronutrients125149.1 (2.8)0.22 (−0.05 to 0.49)0.117 Head circumference (cm)¶ Folic acid135033.1 (1.6)Iron-folic acid127833.2 (1.6)0.11 (−0.06 to 0.28)0.207Multiple micronutrients123433.1 (1.6)0.02 (−0.16 to 0.21)0.8 Haemoglobin** (g/l) Folic acid218105.3 (14.2)Iron-folic acid193110.1 (14.8)5.0 (2.0 to 8.0)0.001Multiple micronutrients188111.8 (14.1)6.9 (4.1 to 9.6)<0.001 Anaemia¶ (<110 g/l) Folic acid133 (61.0)—Iron-folic acid87 (45.1)—0.74 (0.61 to 0.91)0.003Multiple micronutrients81 (43.1)—0.72 (0.59 to 0.88)0.001\n*If applicable.']	micronutrients81	CHEBI_EXT	[25944]	[25960]	BMJ_2008_Nov_7_337_a2001_T181
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_111	[26111]	[26201]	['‡Data missing for 121 in folic acid, 67 in iron-folic acid, 88 in multiple micronutrients.']	folic acid	CHEBI_EXT	[26136]	[26146]	BMJ_2008_Nov_7_337_a2001_T182
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_111	[26111]	[26201]	['‡Data missing for 121 in folic acid, 67 in iron-folic acid, 88 in multiple micronutrients.']	iron	CHEBI_EXT	[26154]	[26158]	BMJ_2008_Nov_7_337_a2001_T183
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_111	[26111]	[26201]	['‡Data missing for 121 in folic acid, 67 in iron-folic acid, 88 in multiple micronutrients.']	folic acid	CHEBI_EXT	[26159]	[26169]	BMJ_2008_Nov_7_337_a2001_T184
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_111	[26111]	[26201]	['‡Data missing for 121 in folic acid, 67 in iron-folic acid, 88 in multiple micronutrients.']	micronutrients	CHEBI_EXT	[26186]	[26200]	BMJ_2008_Nov_7_337_a2001_T185
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_112	[26202]	[26294]	['§Data missing for 299 in folic acid, 239 in iron-folic acid, 243 in multiple micronutrients.']	folic acid	CHEBI_EXT	[26227]	[26237]	BMJ_2008_Nov_7_337_a2001_T186
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_112	[26202]	[26294]	['§Data missing for 299 in folic acid, 239 in iron-folic acid, 243 in multiple micronutrients.']	iron	CHEBI_EXT	[26246]	[26250]	BMJ_2008_Nov_7_337_a2001_T187
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_112	[26202]	[26294]	['§Data missing for 299 in folic acid, 239 in iron-folic acid, 243 in multiple micronutrients.']	folic acid	CHEBI_EXT	[26251]	[26261]	BMJ_2008_Nov_7_337_a2001_T188
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_112	[26202]	[26294]	['§Data missing for 299 in folic acid, 239 in iron-folic acid, 243 in multiple micronutrients.']	micronutrients	CHEBI_EXT	[26279]	[26293]	BMJ_2008_Nov_7_337_a2001_T189
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_113	[26295]	[26387]	['¶Data missing for 316 in folic acid, 260 in iron-folic acid, 260 in multiple micronutrients.']	folic acid	CHEBI_EXT	[26320]	[26330]	BMJ_2008_Nov_7_337_a2001_T190
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_113	[26295]	[26387]	['¶Data missing for 316 in folic acid, 260 in iron-folic acid, 260 in multiple micronutrients.']	iron	CHEBI_EXT	[26339]	[26343]	BMJ_2008_Nov_7_337_a2001_T191
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_113	[26295]	[26387]	['¶Data missing for 316 in folic acid, 260 in iron-folic acid, 260 in multiple micronutrients.']	folic acid	CHEBI_EXT	[26344]	[26354]	BMJ_2008_Nov_7_337_a2001_T192
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_113	[26295]	[26387]	['¶Data missing for 316 in folic acid, 260 in iron-folic acid, 260 in multiple micronutrients.']	micronutrients	CHEBI_EXT	[26372]	[26386]	BMJ_2008_Nov_7_337_a2001_T193
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_114	[26388]	[26512]	['**In subsample of 599 pregnant women with birth outcome who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	pregnant	GO_BP_EXT	[26410]	[26418]	BMJ_2008_Nov_7_337_a2001_T606
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_114	[26388]	[26512]	['**In subsample of 599 pregnant women with birth outcome who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	women	NCBITAXON_EXT	[26419]	[26424]	BMJ_2008_Nov_7_337_a2001_T826
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_114	[26388]	[26512]	['**In subsample of 599 pregnant women with birth outcome who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	women	UBERON_EXT	[26419]	[26424]	BMJ_2008_Nov_7_337_a2001_T948
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_114	[26388]	[26512]	['**In subsample of 599 pregnant women with birth outcome who were consecutively enrolled from 6 July 2004 to 28 October 2005.']	birth	GO_BP_EXT	[26430]	[26435]	BMJ_2008_Nov_7_337_a2001_T607
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_115	[26513]	[26603]	['The intracluster correlation coefficient for gestation at birth was 0.02 (0.004 to 0.036).']	gestation	GO_BP_EXT	[26558]	[26567]	BMJ_2008_Nov_7_337_a2001_T608
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_115	[26513]	[26603]	['The intracluster correlation coefficient for gestation at birth was 0.02 (0.004 to 0.036).']	birth	GO_BP_EXT	[26571]	[26576]	BMJ_2008_Nov_7_337_a2001_T609
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	gestation	GO_BP_EXT	[26670]	[26679]	BMJ_2008_Nov_7_337_a2001_T610
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	iron	CHEBI_EXT	[26731]	[26735]	BMJ_2008_Nov_7_337_a2001_T194
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	folic acid	CHEBI_EXT	[26736]	[26746]	BMJ_2008_Nov_7_337_a2001_T195
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	micronutrient	CHEBI_EXT	[26814]	[26827]	BMJ_2008_Nov_7_337_a2001_T196
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	folic acid	CHEBI_EXT	[26848]	[26858]	BMJ_2008_Nov_7_337_a2001_T197
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	gestation	GO_BP_EXT	[26896]	[26905]	BMJ_2008_Nov_7_337_a2001_T611
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	iron	CHEBI_EXT	[26913]	[26917]	BMJ_2008_Nov_7_337_a2001_T198
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	folic acid	CHEBI_EXT	[26918]	[26928]	BMJ_2008_Nov_7_337_a2001_T199
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	delivery	GO_BP_EXT	[26992]	[27000]	BMJ_2008_Nov_7_337_a2001_T612
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_116	[26604]	[27148]	['Table 4 shows there was a significant increase in the duration of gestation of 0.23 weeks (0.10 to 0.36 weeks, P=0.001) in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks, P=0.004) in the multiple micronutrient group compared with folic acid.The increase in the mean duration of gestation in the iron-folic acid group corresponded with a 21% reduction in the risk of preterm delivery (<37 weeks) (P=0.13) and a significant 50% reduction in the risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	delivery	GO_BP_EXT	[27083]	[27091]	BMJ_2008_Nov_7_337_a2001_T613
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	folic acid	CHEBI_EXT	[27163]	[27173]	BMJ_2008_Nov_7_337_a2001_T200
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	gestation	GO_BP_EXT	[27218]	[27227]	BMJ_2008_Nov_7_337_a2001_T614
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	micronutrient	CHEBI_EXT	[27253]	[27266]	BMJ_2008_Nov_7_337_a2001_T201
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	delivery	GO_BP_EXT	[27341]	[27349]	BMJ_2008_Nov_7_337_a2001_T615
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	delivery	GO_BP_EXT	[27380]	[27388]	BMJ_2008_Nov_7_337_a2001_T616
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_118	[27459]	[27596]	['The intracluster correlation coefficient for birth length was 0.03 (0.007 to 0.047) and for head circumference was 0.08 (0.050 to 0.101).']	birth	GO_BP_EXT	[27504]	[27509]	BMJ_2008_Nov_7_337_a2001_T617
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_118	[27459]	[27596]	['The intracluster correlation coefficient for birth length was 0.03 (0.007 to 0.047) and for head circumference was 0.08 (0.050 to 0.101).']	head	UBERON_EXT	[27551]	[27555]	BMJ_2008_Nov_7_337_a2001_T949
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_119	[27597]	[27760]	['Table 4 shows that in the iron-folic acid group there was a significant increase in birth length (0.24 cm; 0.02 to 0.46 cm, P=0.03) compared with folic acid alone.']	iron	CHEBI_EXT	[27623]	[27627]	BMJ_2008_Nov_7_337_a2001_T202
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_119	[27597]	[27760]	['Table 4 shows that in the iron-folic acid group there was a significant increase in birth length (0.24 cm; 0.02 to 0.46 cm, P=0.03) compared with folic acid alone.']	folic acid	CHEBI_EXT	[27628]	[27638]	BMJ_2008_Nov_7_337_a2001_T203
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_119	[27597]	[27760]	['Table 4 shows that in the iron-folic acid group there was a significant increase in birth length (0.24 cm; 0.02 to 0.46 cm, P=0.03) compared with folic acid alone.']	birth	GO_BP_EXT	[27681]	[27686]	BMJ_2008_Nov_7_337_a2001_T618
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_119	[27597]	[27760]	['Table 4 shows that in the iron-folic acid group there was a significant increase in birth length (0.24 cm; 0.02 to 0.46 cm, P=0.03) compared with folic acid alone.']	folic acid	CHEBI_EXT	[27743]	[27753]	BMJ_2008_Nov_7_337_a2001_T204
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_120	[27761]	[27986]	['There was no significant effect of iron-folic acid on mean head circumference (P=0.21).There were no significant effects of the multiple micronutrients on either mean birth length (P=0.12) or mean head circumference (P=0.80).']	iron	CHEBI_EXT	[27796]	[27800]	BMJ_2008_Nov_7_337_a2001_T205
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_120	[27761]	[27986]	['There was no significant effect of iron-folic acid on mean head circumference (P=0.21).There were no significant effects of the multiple micronutrients on either mean birth length (P=0.12) or mean head circumference (P=0.80).']	folic acid	CHEBI_EXT	[27801]	[27811]	BMJ_2008_Nov_7_337_a2001_T206
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_120	[27761]	[27986]	['There was no significant effect of iron-folic acid on mean head circumference (P=0.21).There were no significant effects of the multiple micronutrients on either mean birth length (P=0.12) or mean head circumference (P=0.80).']	head	UBERON_EXT	[27820]	[27824]	BMJ_2008_Nov_7_337_a2001_T950
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_120	[27761]	[27986]	['There was no significant effect of iron-folic acid on mean head circumference (P=0.21).There were no significant effects of the multiple micronutrients on either mean birth length (P=0.12) or mean head circumference (P=0.80).']	micronutrients	CHEBI_EXT	[27898]	[27912]	BMJ_2008_Nov_7_337_a2001_T207
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_120	[27761]	[27986]	['There was no significant effect of iron-folic acid on mean head circumference (P=0.21).There were no significant effects of the multiple micronutrients on either mean birth length (P=0.12) or mean head circumference (P=0.80).']	birth	GO_BP_EXT	[27928]	[27933]	BMJ_2008_Nov_7_337_a2001_T619
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_120	[27761]	[27986]	['There was no significant effect of iron-folic acid on mean head circumference (P=0.21).There were no significant effects of the multiple micronutrients on either mean birth length (P=0.12) or mean head circumference (P=0.80).']	head	UBERON_EXT	[27958]	[27962]	BMJ_2008_Nov_7_337_a2001_T951
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	folic acid	CHEBI_EXT	[28001]	[28011]	BMJ_2008_Nov_7_337_a2001_T208
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	birth	GO_BP_EXT	[28042]	[28047]	BMJ_2008_Nov_7_337_a2001_T620
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	gestation	GO_BP_EXT	[28086]	[28095]	BMJ_2008_Nov_7_337_a2001_T621
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	delivery	GO_BP_EXT	[28099]	[28107]	BMJ_2008_Nov_7_337_a2001_T622
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	iron	CHEBI_EXT	[28155]	[28159]	BMJ_2008_Nov_7_337_a2001_T209
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	folic acid	CHEBI_EXT	[28160]	[28170]	BMJ_2008_Nov_7_337_a2001_T210
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	micronutrients	CHEBI_EXT	[28199]	[28213]	BMJ_2008_Nov_7_337_a2001_T211
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	gestation	GO_BP_EXT	[28264]	[28273]	BMJ_2008_Nov_7_337_a2001_T623
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	birth	GO_BP_EXT	[28317]	[28322]	BMJ_2008_Nov_7_337_a2001_T624
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	iron	CHEBI_EXT	[28334]	[28338]	BMJ_2008_Nov_7_337_a2001_T212
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	folic acid	CHEBI_EXT	[28339]	[28349]	BMJ_2008_Nov_7_337_a2001_T213
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	micronutrients	CHEBI_EXT	[28372]	[28386]	BMJ_2008_Nov_7_337_a2001_T214
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	folic acid	CHEBI_EXT	[28414]	[28424]	BMJ_2008_Nov_7_337_a2001_T215
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	nutrient	CHEBI_EXT	[28437]	[28445]	BMJ_2008_Nov_7_337_a2001_T216
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	haemoglobin	CHEBI_EXT	[28474]	[28485]	BMJ_2008_Nov_7_337_a2001_T217
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	haemoglobin	CHEBI_EXT	[28474]	[28485]	BMJ_2008_Nov_7_337_a2001_T761
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	Haemoglobin	CHEBI_EXT	[28500]	[28511]	BMJ_2008_Nov_7_337_a2001_T218
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	Haemoglobin	CHEBI_EXT	[28500]	[28511]	BMJ_2008_Nov_7_337_a2001_T762
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	women	NCBITAXON_EXT	[28543]	[28548]	BMJ_2008_Nov_7_337_a2001_T827
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_122	[28427]	[28572]	['Impact of nutrient supplementation on maternal haemoglobin concentration\nHaemoglobin samples were available for 599 women in the third trimester.']	women	UBERON_EXT	[28543]	[28548]	BMJ_2008_Nov_7_337_a2001_T952
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_123	[28573]	[28763]	['The baseline characteristics for these women were balanced across the treatment groups, and there were no significant differences between the women with and without haemoglobin measurements.']	women	NCBITAXON_EXT	[28612]	[28617]	BMJ_2008_Nov_7_337_a2001_T828
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_123	[28573]	[28763]	['The baseline characteristics for these women were balanced across the treatment groups, and there were no significant differences between the women with and without haemoglobin measurements.']	women	UBERON_EXT	[28612]	[28617]	BMJ_2008_Nov_7_337_a2001_T953
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_123	[28573]	[28763]	['The baseline characteristics for these women were balanced across the treatment groups, and there were no significant differences between the women with and without haemoglobin measurements.']	women	NCBITAXON_EXT	[28715]	[28720]	BMJ_2008_Nov_7_337_a2001_T829
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_123	[28573]	[28763]	['The baseline characteristics for these women were balanced across the treatment groups, and there were no significant differences between the women with and without haemoglobin measurements.']	women	UBERON_EXT	[28715]	[28720]	BMJ_2008_Nov_7_337_a2001_T954
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_123	[28573]	[28763]	['The baseline characteristics for these women were balanced across the treatment groups, and there were no significant differences between the women with and without haemoglobin measurements.']	haemoglobin	CHEBI_EXT	[28738]	[28749]	BMJ_2008_Nov_7_337_a2001_T219
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_123	[28573]	[28763]	['The baseline characteristics for these women were balanced across the treatment groups, and there were no significant differences between the women with and without haemoglobin measurements.']	haemoglobin	CHEBI_EXT	[28738]	[28749]	BMJ_2008_Nov_7_337_a2001_T763
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	gestation	GO_BP_EXT	[28817]	[28826]	BMJ_2008_Nov_7_337_a2001_T625
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	haemoglobin	CHEBI_EXT	[28830]	[28841]	BMJ_2008_Nov_7_337_a2001_T220
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	haemoglobin	CHEBI_EXT	[28830]	[28841]	BMJ_2008_Nov_7_337_a2001_T764
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	folic acid	CHEBI_EXT	[28944]	[28954]	BMJ_2008_Nov_7_337_a2001_T221
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	iron	CHEBI_EXT	[28956]	[28960]	BMJ_2008_Nov_7_337_a2001_T222
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	folic acid	CHEBI_EXT	[28961]	[28971]	BMJ_2008_Nov_7_337_a2001_T223
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_124	[28764]	[29021]	['Also there was no significant difference in the mean gestation at haemoglobin testing (P=0.54), which was 32.0 weeks (SD 2.6), 31.9 weeks (SD 2.8), and 32.2 weeks (SD 3.1) for the folic acid, iron-folic acid, and multiple micronutrient groups, respectively.']	micronutrient	CHEBI_EXT	[28986]	[28999]	BMJ_2008_Nov_7_337_a2001_T224
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_125	[29022]	[29199]	['There was a significant increase in haemoglobin concentration with both iron-folic acid and multiple micronutrients compared with folic acid (P=0.001 and P<0.001, respectively).']	haemoglobin	CHEBI_EXT	[29058]	[29069]	BMJ_2008_Nov_7_337_a2001_T225
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_125	[29022]	[29199]	['There was a significant increase in haemoglobin concentration with both iron-folic acid and multiple micronutrients compared with folic acid (P=0.001 and P<0.001, respectively).']	haemoglobin	CHEBI_EXT	[29058]	[29069]	BMJ_2008_Nov_7_337_a2001_T765
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_125	[29022]	[29199]	['There was a significant increase in haemoglobin concentration with both iron-folic acid and multiple micronutrients compared with folic acid (P=0.001 and P<0.001, respectively).']	iron	CHEBI_EXT	[29094]	[29098]	BMJ_2008_Nov_7_337_a2001_T226
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_125	[29022]	[29199]	['There was a significant increase in haemoglobin concentration with both iron-folic acid and multiple micronutrients compared with folic acid (P=0.001 and P<0.001, respectively).']	folic acid	CHEBI_EXT	[29099]	[29109]	BMJ_2008_Nov_7_337_a2001_T227
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_125	[29022]	[29199]	['There was a significant increase in haemoglobin concentration with both iron-folic acid and multiple micronutrients compared with folic acid (P=0.001 and P<0.001, respectively).']	micronutrients	CHEBI_EXT	[29123]	[29137]	BMJ_2008_Nov_7_337_a2001_T228
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_125	[29022]	[29199]	['There was a significant increase in haemoglobin concentration with both iron-folic acid and multiple micronutrients compared with folic acid (P=0.001 and P<0.001, respectively).']	folic acid	CHEBI_EXT	[29152]	[29162]	BMJ_2008_Nov_7_337_a2001_T229
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	iron	CHEBI_EXT	[29212]	[29216]	BMJ_2008_Nov_7_337_a2001_T230
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	folic acid	CHEBI_EXT	[29217]	[29227]	BMJ_2008_Nov_7_337_a2001_T231
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	micronutrient	CHEBI_EXT	[29245]	[29258]	BMJ_2008_Nov_7_337_a2001_T232
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	women	NCBITAXON_EXT	[29297]	[29302]	BMJ_2008_Nov_7_337_a2001_T830
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	women	UBERON_EXT	[29297]	[29302]	BMJ_2008_Nov_7_337_a2001_T955
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	perinatal	GO_BP_EXT	[29386]	[29395]	BMJ_2008_Nov_7_337_a2001_T626
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	perinatal	UBERON_EXT	[29386]	[29395]	BMJ_2008_Nov_7_337_a2001_T956
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	perinatal	GO_BP_EXT	[29468]	[29477]	BMJ_2008_Nov_7_337_a2001_T627
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	perinatal	UBERON_EXT	[29468]	[29477]	BMJ_2008_Nov_7_337_a2001_T957
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	neonatal	UBERON_EXT	[29511]	[29519]	BMJ_2008_Nov_7_337_a2001_T958
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	iron	CHEBI_EXT	[29545]	[29549]	BMJ_2008_Nov_7_337_a2001_T233
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	folic acid	CHEBI_EXT	[29550]	[29560]	BMJ_2008_Nov_7_337_a2001_T234
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	micronutrients	CHEBI_EXT	[29586]	[29600]	BMJ_2008_Nov_7_337_a2001_T235
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	folic acid	CHEBI_EXT	[29631]	[29641]	BMJ_2008_Nov_7_337_a2001_T236
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	Mortality	GO_BP_EXT	[29686]	[29695]	BMJ_2008_Nov_7_337_a2001_T628
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	births	GO_BP_EXT	[29719]	[29725]	BMJ_2008_Nov_7_337_a2001_T629
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	Folic acidIron	CHEBI_EXT	[29726]	[29740]	BMJ_2008_Nov_7_337_a2001_T237
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	folic acidMultiple	CHEBI_EXT	[29741]	[29759]	BMJ_2008_Nov_7_337_a2001_T238
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	micronutrientsRelative	CHEBI_EXT	[29760]	[29782]	BMJ_2008_Nov_7_337_a2001_T239
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	folic acid	CHEBI_EXT	[29879]	[29889]	BMJ_2008_Nov_7_337_a2001_T240
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	folic acidMultiple	CHEBI_EXT	[29892]	[29910]	BMJ_2008_Nov_7_337_a2001_T241
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	micronutrients	CHEBI_EXT	[29911]	[29925]	BMJ_2008_Nov_7_337_a2001_T242
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	folic acidPregnancies	CHEBI_EXT	[29928]	[29949]	BMJ_2008_Nov_7_337_a2001_T243
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	stillbirth	GO_BP_EXT	[29970]	[29980]	BMJ_2008_Nov_7_337_a2001_T630
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	Stillbirths	GO_BP_EXT	[30005]	[30016]	BMJ_2008_Nov_7_337_a2001_T631
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	neonatal	UBERON_EXT	[30118]	[30126]	BMJ_2008_Nov_7_337_a2001_T959
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	deaths3320	GO_BP_EXT	[30127]	[30137]	BMJ_2008_Nov_7_337_a2001_T632
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	neonatal	UBERON_EXT	[30195]	[30203]	BMJ_2008_Nov_7_337_a2001_T960
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	deaths2414	GO_BP_EXT	[30204]	[30214]	BMJ_2008_Nov_7_337_a2001_T633
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	Perinatal	GO_BP_EXT	[30265]	[30274]	BMJ_2008_Nov_7_337_a2001_T634
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	Perinatal	UBERON_EXT	[30265]	[30274]	BMJ_2008_Nov_7_337_a2001_T961
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	deaths7645	GO_BP_EXT	[30275]	[30285]	BMJ_2008_Nov_7_337_a2001_T635
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_129	[30423]	[30654]	['Post hoc analyses also showed no effect of iron-folic acid compared with folic acid on the stillbirth rate, though there was a non-significant increase of 39% (relative risk 1.39, 0.95 to 2.04) in the multiple micronutrients group.']	iron	CHEBI_EXT	[30466]	[30470]	BMJ_2008_Nov_7_337_a2001_T244
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_129	[30423]	[30654]	['Post hoc analyses also showed no effect of iron-folic acid compared with folic acid on the stillbirth rate, though there was a non-significant increase of 39% (relative risk 1.39, 0.95 to 2.04) in the multiple micronutrients group.']	folic acid	CHEBI_EXT	[30471]	[30481]	BMJ_2008_Nov_7_337_a2001_T245
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_129	[30423]	[30654]	['Post hoc analyses also showed no effect of iron-folic acid compared with folic acid on the stillbirth rate, though there was a non-significant increase of 39% (relative risk 1.39, 0.95 to 2.04) in the multiple micronutrients group.']	folic acid	CHEBI_EXT	[30496]	[30506]	BMJ_2008_Nov_7_337_a2001_T246
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_129	[30423]	[30654]	['Post hoc analyses also showed no effect of iron-folic acid compared with folic acid on the stillbirth rate, though there was a non-significant increase of 39% (relative risk 1.39, 0.95 to 2.04) in the multiple micronutrients group.']	micronutrients	CHEBI_EXT	[30633]	[30647]	BMJ_2008_Nov_7_337_a2001_T247
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	losses	GO_BP_EXT	[30682]	[30688]	BMJ_2008_Nov_7_337_a2001_T636
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	pregnancies	GO_BP_EXT	[30756]	[30767]	BMJ_2008_Nov_7_337_a2001_T637
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	folic acid	CHEBI_EXT	[30772]	[30782]	BMJ_2008_Nov_7_337_a2001_T248
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	iron	CHEBI_EXT	[30798]	[30802]	BMJ_2008_Nov_7_337_a2001_T249
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	folic acid	CHEBI_EXT	[30803]	[30813]	BMJ_2008_Nov_7_337_a2001_T250
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	micronutrients	CHEBI_EXT	[30843]	[30857]	BMJ_2008_Nov_7_337_a2001_T251
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	iron	CHEBI_EXT	[30929]	[30933]	BMJ_2008_Nov_7_337_a2001_T252
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	folic acid	CHEBI_EXT	[30934]	[30944]	BMJ_2008_Nov_7_337_a2001_T253
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	micronutrients	CHEBI_EXT	[30997]	[31011]	BMJ_2008_Nov_7_337_a2001_T254
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	folic acid	CHEBI_EXT	[31047]	[31057]	BMJ_2008_Nov_7_337_a2001_T255
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	neonatal	UBERON_EXT	[31121]	[31129]	BMJ_2008_Nov_7_337_a2001_T962
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	infants	UBERON_EXT	[31146]	[31153]	BMJ_2008_Nov_7_337_a2001_T963
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	born	GO_BP_EXT	[31154]	[31158]	BMJ_2008_Nov_7_337_a2001_T638
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	women	NCBITAXON_EXT	[31162]	[31167]	BMJ_2008_Nov_7_337_a2001_T831
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	women	UBERON_EXT	[31162]	[31167]	BMJ_2008_Nov_7_337_a2001_T964
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	iron	CHEBI_EXT	[31197]	[31201]	BMJ_2008_Nov_7_337_a2001_T256
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	folic acid	CHEBI_EXT	[31202]	[31212]	BMJ_2008_Nov_7_337_a2001_T257
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	micronutrients	CHEBI_EXT	[31225]	[31239]	BMJ_2008_Nov_7_337_a2001_T258
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	folic acid	CHEBI_EXT	[31254]	[31264]	BMJ_2008_Nov_7_337_a2001_T259
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_132	[31266]	[31481]	['The magnitude of the reduction (54%) was significant for the iron-folic acid group (relative risk 0.46, 0.21 to 0.98) compared with folic acid but not for the multiple micronutrients group (29%; 0.71, 0.36 to 1.39).']	iron	CHEBI_EXT	[31327]	[31331]	BMJ_2008_Nov_7_337_a2001_T260
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_132	[31266]	[31481]	['The magnitude of the reduction (54%) was significant for the iron-folic acid group (relative risk 0.46, 0.21 to 0.98) compared with folic acid but not for the multiple micronutrients group (29%; 0.71, 0.36 to 1.39).']	folic acid	CHEBI_EXT	[31332]	[31342]	BMJ_2008_Nov_7_337_a2001_T261
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_132	[31266]	[31481]	['The magnitude of the reduction (54%) was significant for the iron-folic acid group (relative risk 0.46, 0.21 to 0.98) compared with folic acid but not for the multiple micronutrients group (29%; 0.71, 0.36 to 1.39).']	folic acid	CHEBI_EXT	[31398]	[31408]	BMJ_2008_Nov_7_337_a2001_T262
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_132	[31266]	[31481]	['The magnitude of the reduction (54%) was significant for the iron-folic acid group (relative risk 0.46, 0.21 to 0.98) compared with folic acid but not for the multiple micronutrients group (29%; 0.71, 0.36 to 1.39).']	micronutrients	CHEBI_EXT	[31434]	[31448]	BMJ_2008_Nov_7_337_a2001_T263
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_133	[31482]	[31672]	['Figure 2illustrates cumulative mortality curves for infants from birth to 28 days, with lower mortality rates for neonates whose mothers received iron-folic acid and multiple micronutrients.']	infants	UBERON_EXT	[31534]	[31541]	BMJ_2008_Nov_7_337_a2001_T965
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_133	[31482]	[31672]	['Figure 2illustrates cumulative mortality curves for infants from birth to 28 days, with lower mortality rates for neonates whose mothers received iron-folic acid and multiple micronutrients.']	birth	GO_BP_EXT	[31547]	[31552]	BMJ_2008_Nov_7_337_a2001_T639
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_133	[31482]	[31672]	['Figure 2illustrates cumulative mortality curves for infants from birth to 28 days, with lower mortality rates for neonates whose mothers received iron-folic acid and multiple micronutrients.']	neonates	UBERON_EXT	[31596]	[31604]	BMJ_2008_Nov_7_337_a2001_T966
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_133	[31482]	[31672]	['Figure 2illustrates cumulative mortality curves for infants from birth to 28 days, with lower mortality rates for neonates whose mothers received iron-folic acid and multiple micronutrients.']	iron	CHEBI_EXT	[31628]	[31632]	BMJ_2008_Nov_7_337_a2001_T264
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_133	[31482]	[31672]	['Figure 2illustrates cumulative mortality curves for infants from birth to 28 days, with lower mortality rates for neonates whose mothers received iron-folic acid and multiple micronutrients.']	folic acid	CHEBI_EXT	[31633]	[31643]	BMJ_2008_Nov_7_337_a2001_T265
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_133	[31482]	[31672]	['Figure 2illustrates cumulative mortality curves for infants from birth to 28 days, with lower mortality rates for neonates whose mothers received iron-folic acid and multiple micronutrients.']	micronutrients	CHEBI_EXT	[31657]	[31671]	BMJ_2008_Nov_7_337_a2001_T266
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_134	[31673]	[31809]	['Most of the divergence of the mortality curves occurred in the first seven days after birth, after which the curves were about parallel.']	birth	GO_BP_EXT	[31759]	[31764]	BMJ_2008_Nov_7_337_a2001_T640
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_135	[31810]	[31967]	['The overall differences were of borderline significance (P=0.055), but the difference between iron-folic acid and folic acid alone was significant (P=0.032).']	iron	CHEBI_EXT	[31904]	[31908]	BMJ_2008_Nov_7_337_a2001_T267
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_135	[31810]	[31967]	['The overall differences were of borderline significance (P=0.055), but the difference between iron-folic acid and folic acid alone was significant (P=0.032).']	folic acid	CHEBI_EXT	[31909]	[31919]	BMJ_2008_Nov_7_337_a2001_T268
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_135	[31810]	[31967]	['The overall differences were of borderline significance (P=0.055), but the difference between iron-folic acid and folic acid alone was significant (P=0.032).']	folic acid	CHEBI_EXT	[31924]	[31934]	BMJ_2008_Nov_7_337_a2001_T269
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_136	[31968]	[32153]	['The other individual treatment comparisons (multiple micronutrients v folic acid and multiple micronutrients v iron-folic acid) were not significant (P=0.077 and P=0.708, respectively).']	micronutrients	CHEBI_EXT	[32021]	[32035]	BMJ_2008_Nov_7_337_a2001_T270
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_136	[31968]	[32153]	['The other individual treatment comparisons (multiple micronutrients v folic acid and multiple micronutrients v iron-folic acid) were not significant (P=0.077 and P=0.708, respectively).']	folic acid	CHEBI_EXT	[32038]	[32048]	BMJ_2008_Nov_7_337_a2001_T271
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_136	[31968]	[32153]	['The other individual treatment comparisons (multiple micronutrients v folic acid and multiple micronutrients v iron-folic acid) were not significant (P=0.077 and P=0.708, respectively).']	micronutrients	CHEBI_EXT	[32062]	[32076]	BMJ_2008_Nov_7_337_a2001_T272
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_136	[31968]	[32153]	['The other individual treatment comparisons (multiple micronutrients v folic acid and multiple micronutrients v iron-folic acid) were not significant (P=0.077 and P=0.708, respectively).']	iron	CHEBI_EXT	[32079]	[32083]	BMJ_2008_Nov_7_337_a2001_T273
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_136	[31968]	[32153]	['The other individual treatment comparisons (multiple micronutrients v folic acid and multiple micronutrients v iron-folic acid) were not significant (P=0.077 and P=0.708, respectively).']	folic acid	CHEBI_EXT	[32084]	[32094]	BMJ_2008_Nov_7_337_a2001_T274
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_137	[32155]	[32251]	['Caption (FIG)\n\nFig 2 Cumulative mortality curves for infants from birth to 28 days by treatment.']	infants	UBERON_EXT	[32208]	[32215]	BMJ_2008_Nov_7_337_a2001_T967
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_137	[32155]	[32251]	['Caption (FIG)\n\nFig 2 Cumulative mortality curves for infants from birth to 28 days by treatment.']	birth	GO_BP_EXT	[32221]	[32226]	BMJ_2008_Nov_7_337_a2001_T641
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	iron	CHEBI_EXT	[32317]	[32321]	BMJ_2008_Nov_7_337_a2001_T275
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	folic acid	CHEBI_EXT	[32322]	[32332]	BMJ_2008_Nov_7_337_a2001_T276
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	folic acid	CHEBI_EXT	[32335]	[32345]	BMJ_2008_Nov_7_337_a2001_T277
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	micronutrients	CHEBI_EXT	[32366]	[32380]	BMJ_2008_Nov_7_337_a2001_T278
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	folic acid	CHEBI_EXT	[32383]	[32393]	BMJ_2008_Nov_7_337_a2001_T279
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	micronutrients	CHEBI_EXT	[32414]	[32428]	BMJ_2008_Nov_7_337_a2001_T280
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	iron	CHEBI_EXT	[32431]	[32435]	BMJ_2008_Nov_7_337_a2001_T281
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	folic acid	CHEBI_EXT	[32436]	[32446]	BMJ_2008_Nov_7_337_a2001_T282
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	neonatal	UBERON_EXT	[32461]	[32469]	BMJ_2008_Nov_7_337_a2001_T968
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_138	[32252]	[32509]	['Log rank test of difference: P=0.055 for three groups; 0.032 for iron-folic acid v folic acid; 0.077 for multiple micronutrients v folic acid; 0.708 for multiple micronutrients v iron-folic acid\nThere were 73 neonatal deaths, including three pairs of twins.']	deaths	GO_BP_EXT	[32470]	[32476]	BMJ_2008_Nov_7_337_a2001_T642
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	neonatal	UBERON_EXT	[32532]	[32540]	BMJ_2008_Nov_7_337_a2001_T969
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	deaths	GO_BP_EXT	[32541]	[32547]	BMJ_2008_Nov_7_337_a2001_T643
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	delivery	GO_BP_EXT	[32567]	[32575]	BMJ_2008_Nov_7_337_a2001_T644
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	folic acid	CHEBI_EXT	[32587]	[32597]	BMJ_2008_Nov_7_337_a2001_T283
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	iron	CHEBI_EXT	[32644]	[32648]	BMJ_2008_Nov_7_337_a2001_T284
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	folic acid	CHEBI_EXT	[32649]	[32659]	BMJ_2008_Nov_7_337_a2001_T285
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	micronutrients	CHEBI_EXT	[32686]	[32700]	BMJ_2008_Nov_7_337_a2001_T286
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_140	[32722]	[32925]	['There was also a higher number of deaths from birth asphyxia in the folic acid group (8/73, 11.0%) with the same number in the iron-folic acid (3/73, 4.1%) and multiple micronutrient (3/73, 4.1%) groups.']	deaths	GO_BP_EXT	[32756]	[32762]	BMJ_2008_Nov_7_337_a2001_T645
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_140	[32722]	[32925]	['There was also a higher number of deaths from birth asphyxia in the folic acid group (8/73, 11.0%) with the same number in the iron-folic acid (3/73, 4.1%) and multiple micronutrient (3/73, 4.1%) groups.']	birth	GO_BP_EXT	[32768]	[32773]	BMJ_2008_Nov_7_337_a2001_T646
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_140	[32722]	[32925]	['There was also a higher number of deaths from birth asphyxia in the folic acid group (8/73, 11.0%) with the same number in the iron-folic acid (3/73, 4.1%) and multiple micronutrient (3/73, 4.1%) groups.']	folic acid	CHEBI_EXT	[32790]	[32800]	BMJ_2008_Nov_7_337_a2001_T287
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_140	[32722]	[32925]	['There was also a higher number of deaths from birth asphyxia in the folic acid group (8/73, 11.0%) with the same number in the iron-folic acid (3/73, 4.1%) and multiple micronutrient (3/73, 4.1%) groups.']	iron	CHEBI_EXT	[32849]	[32853]	BMJ_2008_Nov_7_337_a2001_T288
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_140	[32722]	[32925]	['There was also a higher number of deaths from birth asphyxia in the folic acid group (8/73, 11.0%) with the same number in the iron-folic acid (3/73, 4.1%) and multiple micronutrient (3/73, 4.1%) groups.']	folic acid	CHEBI_EXT	[32854]	[32864]	BMJ_2008_Nov_7_337_a2001_T289
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_140	[32722]	[32925]	['There was also a higher number of deaths from birth asphyxia in the folic acid group (8/73, 11.0%) with the same number in the iron-folic acid (3/73, 4.1%) and multiple micronutrient (3/73, 4.1%) groups.']	micronutrient	CHEBI_EXT	[32891]	[32904]	BMJ_2008_Nov_7_337_a2001_T290
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	micronutrients	CHEBI_EXT	[32981]	[32995]	BMJ_2008_Nov_7_337_a2001_T291
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	iron	CHEBI_EXT	[33010]	[33014]	BMJ_2008_Nov_7_337_a2001_T292
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	folic acid	CHEBI_EXT	[33015]	[33025]	BMJ_2008_Nov_7_337_a2001_T293
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	birth	GO_BP_EXT	[33030]	[33035]	BMJ_2008_Nov_7_337_a2001_T647
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	gestation	GO_BP_EXT	[33063]	[33072]	BMJ_2008_Nov_7_337_a2001_T648
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	haemoglobin	CHEBI_EXT	[33074]	[33085]	BMJ_2008_Nov_7_337_a2001_T294
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	haemoglobin	CHEBI_EXT	[33074]	[33085]	BMJ_2008_Nov_7_337_a2001_T766
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	perinatal	GO_BP_EXT	[33104]	[33113]	BMJ_2008_Nov_7_337_a2001_T649
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_141	[32926]	[33124]	['There were no significant differences between multiple micronutrients compared with iron-folic acid for birth anthropometry, duration of gestation, haemoglobin concentration, or perinatal mortality.']	perinatal	UBERON_EXT	[33104]	[33113]	BMJ_2008_Nov_7_337_a2001_T970
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	women	NCBITAXON_EXT	[33168]	[33173]	BMJ_2008_Nov_7_337_a2001_T832
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	women	UBERON_EXT	[33168]	[33173]	BMJ_2008_Nov_7_337_a2001_T971
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	iron	CHEBI_EXT	[33208]	[33212]	BMJ_2008_Nov_7_337_a2001_T295
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	folic acid	CHEBI_EXT	[33213]	[33223]	BMJ_2008_Nov_7_337_a2001_T296
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	pregnancy	GO_BP_EXT	[33238]	[33247]	BMJ_2008_Nov_7_337_a2001_T650
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	delivery	GO_BP_EXT	[33383]	[33391]	BMJ_2008_Nov_7_337_a2001_T651
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	delivery	GO_BP_EXT	[33455]	[33463]	BMJ_2008_Nov_7_337_a2001_T652
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	neonatal	UBERON_EXT	[33523]	[33531]	BMJ_2008_Nov_7_337_a2001_T972
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	death	GO_BP_EXT	[33532]	[33537]	BMJ_2008_Nov_7_337_a2001_T653
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_143	[33539]	[33715]	['With multiple micronutrients the numbers needed to treat would be 5.6 (5.5 to 5.7), 111.1 (111.08 to 111.12), 188.7 (188.69 to 188.71), and 222 (222.19 to 222.21) respectively.']	micronutrients	CHEBI_EXT	[33553]	[33567]	BMJ_2008_Nov_7_337_a2001_T297
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_144	[33717]	[33814]	['Discussion\nIn this trial the response to nutrient supplementation in pregnancy varied by outcome.']	response	GO_BP_EXT	[33746]	[33754]	BMJ_2008_Nov_7_337_a2001_T654
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_144	[33717]	[33814]	['Discussion\nIn this trial the response to nutrient supplementation in pregnancy varied by outcome.']	nutrient	CHEBI_EXT	[33758]	[33766]	BMJ_2008_Nov_7_337_a2001_T298
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_144	[33717]	[33814]	['Discussion\nIn this trial the response to nutrient supplementation in pregnancy varied by outcome.']	pregnancy	GO_BP_EXT	[33786]	[33795]	BMJ_2008_Nov_7_337_a2001_T655
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	folic acid	CHEBI_EXT	[33829]	[33839]	BMJ_2008_Nov_7_337_a2001_T299
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	micronutrient	CHEBI_EXT	[33856]	[33869]	BMJ_2008_Nov_7_337_a2001_T300
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	birth	GO_BP_EXT	[33927]	[33932]	BMJ_2008_Nov_7_337_a2001_T656
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	iron	CHEBI_EXT	[33947]	[33951]	BMJ_2008_Nov_7_337_a2001_T301
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	folic acid	CHEBI_EXT	[33952]	[33962]	BMJ_2008_Nov_7_337_a2001_T302
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_146	[33990]	[34076]	['Iron-folic acid supplements were significantly associated with increased birth length.']	Iron	CHEBI_EXT	[33990]	[33994]	BMJ_2008_Nov_7_337_a2001_T303
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_146	[33990]	[34076]	['Iron-folic acid supplements were significantly associated with increased birth length.']	folic acid	CHEBI_EXT	[33995]	[34005]	BMJ_2008_Nov_7_337_a2001_T304
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_146	[33990]	[34076]	['Iron-folic acid supplements were significantly associated with increased birth length.']	birth	GO_BP_EXT	[34063]	[34068]	BMJ_2008_Nov_7_337_a2001_T657
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_147	[34077]	[34232]	['There was a significant increase in the mean duration of gestation in both the iron-folic acid and multiple micronutrients groups compared with folic acid.']	gestation	GO_BP_EXT	[34134]	[34143]	BMJ_2008_Nov_7_337_a2001_T658
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_147	[34077]	[34232]	['There was a significant increase in the mean duration of gestation in both the iron-folic acid and multiple micronutrients groups compared with folic acid.']	iron	CHEBI_EXT	[34156]	[34160]	BMJ_2008_Nov_7_337_a2001_T305
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_147	[34077]	[34232]	['There was a significant increase in the mean duration of gestation in both the iron-folic acid and multiple micronutrients groups compared with folic acid.']	folic acid	CHEBI_EXT	[34161]	[34171]	BMJ_2008_Nov_7_337_a2001_T306
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_147	[34077]	[34232]	['There was a significant increase in the mean duration of gestation in both the iron-folic acid and multiple micronutrients groups compared with folic acid.']	micronutrients	CHEBI_EXT	[34185]	[34199]	BMJ_2008_Nov_7_337_a2001_T307
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_147	[34077]	[34232]	['There was a significant increase in the mean duration of gestation in both the iron-folic acid and multiple micronutrients groups compared with folic acid.']	folic acid	CHEBI_EXT	[34221]	[34231]	BMJ_2008_Nov_7_337_a2001_T308
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	iron	CHEBI_EXT	[34259]	[34263]	BMJ_2008_Nov_7_337_a2001_T309
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	folic acid	CHEBI_EXT	[34264]	[34274]	BMJ_2008_Nov_7_337_a2001_T310
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	micronutrient	CHEBI_EXT	[34292]	[34305]	BMJ_2008_Nov_7_337_a2001_T311
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	perinatal	GO_BP_EXT	[34347]	[34356]	BMJ_2008_Nov_7_337_a2001_T659
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	perinatal	UBERON_EXT	[34347]	[34356]	BMJ_2008_Nov_7_337_a2001_T973
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	neonatal	UBERON_EXT	[34419]	[34427]	BMJ_2008_Nov_7_337_a2001_T974
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	women	NCBITAXON_EXT	[34441]	[34446]	BMJ_2008_Nov_7_337_a2001_T833
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	women	UBERON_EXT	[34441]	[34446]	BMJ_2008_Nov_7_337_a2001_T975
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	iron	CHEBI_EXT	[34481]	[34485]	BMJ_2008_Nov_7_337_a2001_T312
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	folic acid	CHEBI_EXT	[34486]	[34496]	BMJ_2008_Nov_7_337_a2001_T313
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	folic acid	CHEBI_EXT	[34511]	[34521]	BMJ_2008_Nov_7_337_a2001_T314
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	micronutrients	CHEBI_EXT	[34586]	[34600]	BMJ_2008_Nov_7_337_a2001_T315
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	iron	CHEBI_EXT	[34605]	[34609]	BMJ_2008_Nov_7_337_a2001_T316
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	folic acid	CHEBI_EXT	[34610]	[34620]	BMJ_2008_Nov_7_337_a2001_T317
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	haemoglobin	CHEBI_EXT	[34675]	[34686]	BMJ_2008_Nov_7_337_a2001_T318
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	haemoglobin	CHEBI_EXT	[34675]	[34686]	BMJ_2008_Nov_7_337_a2001_T767
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	folic acid	CHEBI_EXT	[34738]	[34748]	BMJ_2008_Nov_7_337_a2001_T319
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	women	NCBITAXON_EXT	[34778]	[34783]	BMJ_2008_Nov_7_337_a2001_T834
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	women	UBERON_EXT	[34778]	[34783]	BMJ_2008_Nov_7_337_a2001_T976
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	antenatal	GO_BP_EXT	[34846]	[34855]	BMJ_2008_Nov_7_337_a2001_T660
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	nutrient	CHEBI_EXT	[34856]	[34864]	BMJ_2008_Nov_7_337_a2001_T320
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	haemoglobin	CHEBI_EXT	[34919]	[34930]	BMJ_2008_Nov_7_337_a2001_T321
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	haemoglobin	CHEBI_EXT	[34919]	[34930]	BMJ_2008_Nov_7_337_a2001_T768
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	pregnancy	GO_BP_EXT	[34953]	[34962]	BMJ_2008_Nov_7_337_a2001_T661
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	pregnancy	GO_BP_EXT	[34999]	[35008]	BMJ_2008_Nov_7_337_a2001_T662
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	delivery	GO_BP_EXT	[35029]	[35037]	BMJ_2008_Nov_7_337_a2001_T663
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	neonatal	UBERON_EXT	[35048]	[35056]	BMJ_2008_Nov_7_337_a2001_T977
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	iron	CHEBI_EXT	[35083]	[35087]	BMJ_2008_Nov_7_337_a2001_T322
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	folic acid	CHEBI_EXT	[35088]	[35098]	BMJ_2008_Nov_7_337_a2001_T323
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	micronutrients	CHEBI_EXT	[35112]	[35126]	BMJ_2008_Nov_7_337_a2001_T324
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	gestation	GO_BP_EXT	[35146]	[35155]	BMJ_2008_Nov_7_337_a2001_T664
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	neonatal	UBERON_EXT	[35160]	[35168]	BMJ_2008_Nov_7_337_a2001_T978
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	iron	CHEBI_EXT	[35205]	[35209]	BMJ_2008_Nov_7_337_a2001_T325
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	iron	CHEBI_EXT	[35279]	[35283]	BMJ_2008_Nov_7_337_a2001_T326
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	pregnancy	GO_BP_EXT	[35287]	[35296]	BMJ_2008_Nov_7_337_a2001_T665
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	iron	CHEBI_EXT	[35318]	[35322]	BMJ_2008_Nov_7_337_a2001_T327
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	folic acid	CHEBI_EXT	[35323]	[35333]	BMJ_2008_Nov_7_337_a2001_T328
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	micronutrient	CHEBI_EXT	[35372]	[35385]	BMJ_2008_Nov_7_337_a2001_T329
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	supplements	CHEBI_EXT	[35386]	[35397]	BMJ_2008_Nov_7_337_a2001_T330
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	neonatal	UBERON_EXT	[35421]	[35429]	BMJ_2008_Nov_7_337_a2001_T979
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	iron	CHEBI_EXT	[35489]	[35493]	BMJ_2008_Nov_7_337_a2001_T331
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	gestation	GO_BP_EXT	[35540]	[35549]	BMJ_2008_Nov_7_337_a2001_T666
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	delivery	GO_BP_EXT	[35573]	[35581]	BMJ_2008_Nov_7_337_a2001_T667
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	neonatal	UBERON_EXT	[35702]	[35710]	BMJ_2008_Nov_7_337_a2001_T980
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	iron	CHEBI_EXT	[35762]	[35766]	BMJ_2008_Nov_7_337_a2001_T332
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	folic acid	CHEBI_EXT	[35767]	[35777]	BMJ_2008_Nov_7_337_a2001_T333
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	micronutrients	CHEBI_EXT	[35791]	[35805]	BMJ_2008_Nov_7_337_a2001_T334
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	iron	CHEBI_EXT	[35883]	[35887]	BMJ_2008_Nov_7_337_a2001_T335
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	neonatal	UBERON_EXT	[35952]	[35960]	BMJ_2008_Nov_7_337_a2001_T981
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	micronutrients	CHEBI_EXT	[36011]	[36025]	BMJ_2008_Nov_7_337_a2001_T336
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	iron	CHEBI_EXT	[36040]	[36044]	BMJ_2008_Nov_7_337_a2001_T337
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	folic acid	CHEBI_EXT	[36045]	[36055]	BMJ_2008_Nov_7_337_a2001_T338
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	micronutrients	CHEBI_EXT	[36094]	[36108]	BMJ_2008_Nov_7_337_a2001_T339
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	iron	CHEBI_EXT	[36138]	[36142]	BMJ_2008_Nov_7_337_a2001_T340
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_155	[36163]	[36379]	['In our trial, the multiple micronutrient supplements were associated with a significant increase in birth weight compared with folic acid, but this did not translate into significant reductions in neonatal mortality.']	micronutrient	CHEBI_EXT	[36190]	[36203]	BMJ_2008_Nov_7_337_a2001_T341
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_155	[36163]	[36379]	['In our trial, the multiple micronutrient supplements were associated with a significant increase in birth weight compared with folic acid, but this did not translate into significant reductions in neonatal mortality.']	birth	GO_BP_EXT	[36263]	[36268]	BMJ_2008_Nov_7_337_a2001_T668
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_155	[36163]	[36379]	['In our trial, the multiple micronutrient supplements were associated with a significant increase in birth weight compared with folic acid, but this did not translate into significant reductions in neonatal mortality.']	folic acid	CHEBI_EXT	[36290]	[36300]	BMJ_2008_Nov_7_337_a2001_T342
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_155	[36163]	[36379]	['In our trial, the multiple micronutrient supplements were associated with a significant increase in birth weight compared with folic acid, but this did not translate into significant reductions in neonatal mortality.']	neonatal	UBERON_EXT	[36360]	[36368]	BMJ_2008_Nov_7_337_a2001_T982
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	neonatal	UBERON_EXT	[36404]	[36412]	BMJ_2008_Nov_7_337_a2001_T983
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	gestation	GO_BP_EXT	[36473]	[36482]	BMJ_2008_Nov_7_337_a2001_T669
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	deliveries	GO_BP_EXT	[36523]	[36533]	BMJ_2008_Nov_7_337_a2001_T670
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	iron	CHEBI_EXT	[36545]	[36549]	BMJ_2008_Nov_7_337_a2001_T343
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	iron	CHEBI_EXT	[36623]	[36627]	BMJ_2008_Nov_7_337_a2001_T344
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	delivery	GO_BP_EXT	[36660]	[36668]	BMJ_2008_Nov_7_337_a2001_T671
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	iron	CHEBI_EXT	[36739]	[36743]	BMJ_2008_Nov_7_337_a2001_T345
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	delivery	GO_BP_EXT	[36799]	[36807]	BMJ_2008_Nov_7_337_a2001_T672
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	birth	GO_BP_EXT	[36846]	[36851]	BMJ_2008_Nov_7_337_a2001_T673
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	infants	UBERON_EXT	[36945]	[36952]	BMJ_2008_Nov_7_337_a2001_T984
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	neonatal	UBERON_EXT	[36970]	[36978]	BMJ_2008_Nov_7_337_a2001_T985
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	babies	UBERON_EXT	[36994]	[37000]	BMJ_2008_Nov_7_337_a2001_T986
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	intrauterine	UBERON_EXT	[37015]	[37027]	BMJ_2008_Nov_7_337_a2001_T987
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	growth	GO_BP_EXT	[37028]	[37034]	BMJ_2008_Nov_7_337_a2001_T674
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	born	GO_BP_EXT	[37044]	[37048]	BMJ_2008_Nov_7_337_a2001_T675
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	birth	GO_BP_EXT	[37084]	[37089]	BMJ_2008_Nov_7_337_a2001_T676
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	infants	UBERON_EXT	[37121]	[37128]	BMJ_2008_Nov_7_337_a2001_T988
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	neonatal	UBERON_EXT	[37154]	[37162]	BMJ_2008_Nov_7_337_a2001_T989
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	deaths	GO_BP_EXT	[37163]	[37169]	BMJ_2008_Nov_7_337_a2001_T677
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	delivery	GO_BP_EXT	[37194]	[37202]	BMJ_2008_Nov_7_337_a2001_T678
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	gestation	GO_BP_EXT	[37301]	[37310]	BMJ_2008_Nov_7_337_a2001_T679
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	delivery	GO_BP_EXT	[37331]	[37339]	BMJ_2008_Nov_7_337_a2001_T680
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	delivery	GO_BP_EXT	[37366]	[37374]	BMJ_2008_Nov_7_337_a2001_T681
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	neonatal	UBERON_EXT	[37429]	[37437]	BMJ_2008_Nov_7_337_a2001_T990
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_161	[37624]	[37810]	['Even though randomisation was by village clusters, there were a large number of clusters (531) with about 180 per treatment group and a relatively small number of births in each cluster.']	births	GO_BP_EXT	[37787]	[37793]	BMJ_2008_Nov_7_337_a2001_T682
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_162	[37811]	[38012]	['Population recruitment of pregnancies allowed complete tracing of fetal losses, including spontaneous and induced abortions and stillbirths, and pregnancy outcomes in both hospital and home deliveries.']	pregnancies	GO_BP_EXT	[37837]	[37848]	BMJ_2008_Nov_7_337_a2001_T683
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_162	[37811]	[38012]	['Population recruitment of pregnancies allowed complete tracing of fetal losses, including spontaneous and induced abortions and stillbirths, and pregnancy outcomes in both hospital and home deliveries.']	losses	GO_BP_EXT	[37883]	[37889]	BMJ_2008_Nov_7_337_a2001_T684
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_162	[37811]	[38012]	['Population recruitment of pregnancies allowed complete tracing of fetal losses, including spontaneous and induced abortions and stillbirths, and pregnancy outcomes in both hospital and home deliveries.']	pregnancy	GO_BP_EXT	[37956]	[37965]	BMJ_2008_Nov_7_337_a2001_T685
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_162	[37811]	[38012]	['Population recruitment of pregnancies allowed complete tracing of fetal losses, including spontaneous and induced abortions and stillbirths, and pregnancy outcomes in both hospital and home deliveries.']	deliveries	GO_BP_EXT	[38001]	[38011]	BMJ_2008_Nov_7_337_a2001_T686
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_164	[38119]	[38355]	['The location of the study in a socioeconomically disadvantaged area of western China allowed us to examine effects of nutrient supplements in a population with the highest rates of low birth weight and neonatal mortality in the country.']	nutrient	CHEBI_EXT	[38237]	[38245]	BMJ_2008_Nov_7_337_a2001_T346
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_164	[38119]	[38355]	['The location of the study in a socioeconomically disadvantaged area of western China allowed us to examine effects of nutrient supplements in a population with the highest rates of low birth weight and neonatal mortality in the country.']	birth	GO_BP_EXT	[38304]	[38309]	BMJ_2008_Nov_7_337_a2001_T687
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_164	[38119]	[38355]	['The location of the study in a socioeconomically disadvantaged area of western China allowed us to examine effects of nutrient supplements in a population with the highest rates of low birth weight and neonatal mortality in the country.']	neonatal	UBERON_EXT	[38321]	[38329]	BMJ_2008_Nov_7_337_a2001_T991
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_165	[38356]	[38484]	['Only 2.3% of the enrolled women were lost to follow-up, and 94% of the liveborn infants were weighed within 72 hour of delivery.']	women	NCBITAXON_EXT	[38382]	[38387]	BMJ_2008_Nov_7_337_a2001_T835
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_165	[38356]	[38484]	['Only 2.3% of the enrolled women were lost to follow-up, and 94% of the liveborn infants were weighed within 72 hour of delivery.']	women	UBERON_EXT	[38382]	[38387]	BMJ_2008_Nov_7_337_a2001_T992
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_165	[38356]	[38484]	['Only 2.3% of the enrolled women were lost to follow-up, and 94% of the liveborn infants were weighed within 72 hour of delivery.']	infants	UBERON_EXT	[38436]	[38443]	BMJ_2008_Nov_7_337_a2001_T993
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_165	[38356]	[38484]	['Only 2.3% of the enrolled women were lost to follow-up, and 94% of the liveborn infants were weighed within 72 hour of delivery.']	delivery	GO_BP_EXT	[38475]	[38483]	BMJ_2008_Nov_7_337_a2001_T688
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	neonatal	UBERON_EXT	[38531]	[38539]	BMJ_2008_Nov_7_337_a2001_T994
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	deaths	GO_BP_EXT	[38540]	[38546]	BMJ_2008_Nov_7_337_a2001_T689
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	neonatal	UBERON_EXT	[38553]	[38561]	BMJ_2008_Nov_7_337_a2001_T995
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	folic acid	CHEBI_EXT	[38585]	[38595]	BMJ_2008_Nov_7_337_a2001_T347
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	child	NCBITAXON_EXT	[38713]	[38718]	BMJ_2008_Nov_7_337_a2001_T836
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	child	UBERON_EXT	[38713]	[38718]	BMJ_2008_Nov_7_337_a2001_T996
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	infant	UBERON_EXT	[38832]	[38838]	BMJ_2008_Nov_7_337_a2001_T997
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	birth	GO_BP_EXT	[38856]	[38861]	BMJ_2008_Nov_7_337_a2001_T690
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	gestation	GO_BP_EXT	[38882]	[38891]	BMJ_2008_Nov_7_337_a2001_T691
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	birth	GO_BP_EXT	[38973]	[38978]	BMJ_2008_Nov_7_337_a2001_T692
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	delivery	GO_BP_EXT	[38995]	[39003]	BMJ_2008_Nov_7_337_a2001_T693
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	perinatal	GO_BP_EXT	[39009]	[39018]	BMJ_2008_Nov_7_337_a2001_T694
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	perinatal	UBERON_EXT	[39009]	[39018]	BMJ_2008_Nov_7_337_a2001_T998
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_168	[39204]	[39358]	['For example, the non-significant reduction in neonatal mortality associated with multiple micronutrients might have been significant with a larger sample.']	neonatal	UBERON_EXT	[39250]	[39258]	BMJ_2008_Nov_7_337_a2001_T999
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_168	[39204]	[39358]	['For example, the non-significant reduction in neonatal mortality associated with multiple micronutrients might have been significant with a larger sample.']	micronutrients	CHEBI_EXT	[39294]	[39308]	BMJ_2008_Nov_7_337_a2001_T348
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_170	[39551]	[39754]	['The balance of treatments by area and therefore by service providers reduced the likelihood of any systematic differences in misclassification of stillbirths and early neonatal deaths by treatment group.']	neonatal	UBERON_EXT	[39719]	[39727]	BMJ_2008_Nov_7_337_a2001_T1000
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_170	[39551]	[39754]	['The balance of treatments by area and therefore by service providers reduced the likelihood of any systematic differences in misclassification of stillbirths and early neonatal deaths by treatment group.']	deaths	GO_BP_EXT	[39728]	[39734]	BMJ_2008_Nov_7_337_a2001_T695
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_171	[39755]	[39863]	['The duration of gestation was measured by asking the mother to recall the date of her last menstrual period.']	gestation	GO_BP_EXT	[39771]	[39780]	BMJ_2008_Nov_7_337_a2001_T696
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_171	[39755]	[39863]	['The duration of gestation was measured by asking the mother to recall the date of her last menstrual period.']	menstrual	GO_BP_EXT	[39846]	[39855]	BMJ_2008_Nov_7_337_a2001_T697
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_171	[39755]	[39863]	['The duration of gestation was measured by asking the mother to recall the date of her last menstrual period.']	menstrual period	UBERON_EXT	[39846]	[39862]	BMJ_2008_Nov_7_337_a2001_T1001
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	reproduction	GO_BP_EXT	[39909]	[39921]	BMJ_2008_Nov_7_337_a2001_T698
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	child	NCBITAXON_EXT	[39941]	[39946]	BMJ_2008_Nov_7_337_a2001_T837
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	child	UBERON_EXT	[39941]	[39946]	BMJ_2008_Nov_7_337_a2001_T1002
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	menstrual	GO_BP_EXT	[40045]	[40054]	BMJ_2008_Nov_7_337_a2001_T699
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	menstrual period	UBERON_EXT	[40045]	[40061]	BMJ_2008_Nov_7_337_a2001_T1003
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	perinatal	GO_BP_EXT	[40072]	[40081]	BMJ_2008_Nov_7_337_a2001_T700
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	perinatal	UBERON_EXT	[40072]	[40081]	BMJ_2008_Nov_7_337_a2001_T1004
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	neonatal	UBERON_EXT	[40174]	[40182]	BMJ_2008_Nov_7_337_a2001_T1005
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	GO_BP_EXT	[40187]	[40196]	BMJ_2008_Nov_7_337_a2001_T701
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	UBERON_EXT	[40187]	[40196]	BMJ_2008_Nov_7_337_a2001_T1006
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	micronutrient	CHEBI_EXT	[40284]	[40297]	BMJ_2008_Nov_7_337_a2001_T349
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	iron	CHEBI_EXT	[40333]	[40337]	BMJ_2008_Nov_7_337_a2001_T350
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	folic acid	CHEBI_EXT	[40338]	[40348]	BMJ_2008_Nov_7_337_a2001_T351
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	micronutrient	CHEBI_EXT	[40401]	[40414]	BMJ_2008_Nov_7_337_a2001_T352
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	neonatal	UBERON_EXT	[40481]	[40489]	BMJ_2008_Nov_7_337_a2001_T1007
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	GO_BP_EXT	[40494]	[40503]	BMJ_2008_Nov_7_337_a2001_T702
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	UBERON_EXT	[40494]	[40503]	BMJ_2008_Nov_7_337_a2001_T1008
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	iron	CHEBI_EXT	[40528]	[40532]	BMJ_2008_Nov_7_337_a2001_T353
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	folic acid	CHEBI_EXT	[40533]	[40543]	BMJ_2008_Nov_7_337_a2001_T354
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	neonatal	UBERON_EXT	[40585]	[40593]	BMJ_2008_Nov_7_337_a2001_T1009
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	GO_BP_EXT	[40643]	[40652]	BMJ_2008_Nov_7_337_a2001_T703
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	UBERON_EXT	[40643]	[40652]	BMJ_2008_Nov_7_337_a2001_T1010
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	micronutrients	CHEBI_EXT	[40726]	[40740]	BMJ_2008_Nov_7_337_a2001_T355
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	iron	CHEBI_EXT	[40761]	[40765]	BMJ_2008_Nov_7_337_a2001_T356
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	folic acid	CHEBI_EXT	[40766]	[40776]	BMJ_2008_Nov_7_337_a2001_T357
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	GO_BP_EXT	[40850]	[40859]	BMJ_2008_Nov_7_337_a2001_T704
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	perinatal	UBERON_EXT	[40850]	[40859]	BMJ_2008_Nov_7_337_a2001_T1011
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	micronutrient	CHEBI_EXT	[40884]	[40897]	BMJ_2008_Nov_7_337_a2001_T358
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	neonatal	UBERON_EXT	[40958]	[40966]	BMJ_2008_Nov_7_337_a2001_T1012
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	iron	CHEBI_EXT	[40981]	[40985]	BMJ_2008_Nov_7_337_a2001_T359
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	folic acid	CHEBI_EXT	[40986]	[40996]	BMJ_2008_Nov_7_337_a2001_T360
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	micronutrients	CHEBI_EXT	[41048]	[41062]	BMJ_2008_Nov_7_337_a2001_T361
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	folic acid	CHEBI_EXT	[41083]	[41093]	BMJ_2008_Nov_7_337_a2001_T362
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	iron	CHEBI_EXT	[41130]	[41134]	BMJ_2008_Nov_7_337_a2001_T363
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	folic acid	CHEBI_EXT	[41135]	[41145]	BMJ_2008_Nov_7_337_a2001_T364
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	micronutrients	CHEBI_EXT	[41169]	[41183]	BMJ_2008_Nov_7_337_a2001_T365
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	micronutrients	CHEBI_EXT	[41230]	[41244]	BMJ_2008_Nov_7_337_a2001_T366
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	iron	CHEBI_EXT	[41250]	[41254]	BMJ_2008_Nov_7_337_a2001_T367
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	folic acid	CHEBI_EXT	[41255]	[41265]	BMJ_2008_Nov_7_337_a2001_T368
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	neonatal	UBERON_EXT	[41310]	[41318]	BMJ_2008_Nov_7_337_a2001_T1013
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	iron	CHEBI_EXT	[41427]	[41431]	BMJ_2008_Nov_7_337_a2001_T369
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	pregnancy	GO_BP_EXT	[41451]	[41460]	BMJ_2008_Nov_7_337_a2001_T705
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	iron	CHEBI_EXT	[41548]	[41552]	BMJ_2008_Nov_7_337_a2001_T370
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	iron	CHEBI_EXT	[41590]	[41594]	BMJ_2008_Nov_7_337_a2001_T371
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	newborn	UBERON_EXT	[41620]	[41627]	BMJ_2008_Nov_7_337_a2001_T1014
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	newborn	UBERON_EXT	[41668]	[41675]	BMJ_2008_Nov_7_337_a2001_T1015
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	iron	CHEBI_EXT	[41682]	[41686]	BMJ_2008_Nov_7_337_a2001_T372
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	iron	CHEBI_EXT	[41753]	[41757]	BMJ_2008_Nov_7_337_a2001_T373
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	delivery	GO_BP_EXT	[41772]	[41780]	BMJ_2008_Nov_7_337_a2001_T706
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	delivery	GO_BP_EXT	[41807]	[41815]	BMJ_2008_Nov_7_337_a2001_T707
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	iron	CHEBI_EXT	[41834]	[41838]	BMJ_2008_Nov_7_337_a2001_T374
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	infants	UBERON_EXT	[41853]	[41860]	BMJ_2008_Nov_7_337_a2001_T1016
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_177	[41874]	[42000]	['Birth length was significantly higher and there was a non-significant increase in birth weight in the iron supplemented group.']	Birth	GO_BP_EXT	[41874]	[41879]	BMJ_2008_Nov_7_337_a2001_T708
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_177	[41874]	[42000]	['Birth length was significantly higher and there was a non-significant increase in birth weight in the iron supplemented group.']	birth	GO_BP_EXT	[41956]	[41961]	BMJ_2008_Nov_7_337_a2001_T709
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_177	[41874]	[42000]	['Birth length was significantly higher and there was a non-significant increase in birth weight in the iron supplemented group.']	iron	CHEBI_EXT	[41976]	[41980]	BMJ_2008_Nov_7_337_a2001_T375
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_178	[42001]	[42104]	['There were seven fetal and neonatal deaths in the placebo group and one in the iron supplemented group.']	neonatal	UBERON_EXT	[42028]	[42036]	BMJ_2008_Nov_7_337_a2001_T1017
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_178	[42001]	[42104]	['There were seven fetal and neonatal deaths in the placebo group and one in the iron supplemented group.']	deaths	GO_BP_EXT	[42037]	[42043]	BMJ_2008_Nov_7_337_a2001_T710
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_178	[42001]	[42104]	['There were seven fetal and neonatal deaths in the placebo group and one in the iron supplemented group.']	placebo	CHEBI_EXT	[42051]	[42058]	BMJ_2008_Nov_7_337_a2001_T376
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_178	[42001]	[42104]	['There were seven fetal and neonatal deaths in the placebo group and one in the iron supplemented group.']	iron	CHEBI_EXT	[42080]	[42084]	BMJ_2008_Nov_7_337_a2001_T377
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[42127]	[42131]	BMJ_2008_Nov_7_337_a2001_T378
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	gestation	GO_BP_EXT	[42190]	[42199]	BMJ_2008_Nov_7_337_a2001_T711
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	pregnant	GO_BP_EXT	[42203]	[42211]	BMJ_2008_Nov_7_337_a2001_T712
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	women	NCBITAXON_EXT	[42212]	[42217]	BMJ_2008_Nov_7_337_a2001_T838
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	gestation	GO_BP_EXT	[42283]	[42292]	BMJ_2008_Nov_7_337_a2001_T713
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[42375]	[42379]	BMJ_2008_Nov_7_337_a2001_T379
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	women	NCBITAXON_EXT	[42393]	[42398]	BMJ_2008_Nov_7_337_a2001_T839
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	delivery	GO_BP_EXT	[42516]	[42524]	BMJ_2008_Nov_7_337_a2001_T714
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	women	NCBITAXON_EXT	[42528]	[42533]	BMJ_2008_Nov_7_337_a2001_T840
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[42539]	[42543]	BMJ_2008_Nov_7_337_a2001_T380
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	pregnancy	GO_BP_EXT	[42589]	[42598]	BMJ_2008_Nov_7_337_a2001_T715
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	perinatal	GO_BP_EXT	[42637]	[42646]	BMJ_2008_Nov_7_337_a2001_T716
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	perinatal	UBERON_EXT	[42637]	[42646]	BMJ_2008_Nov_7_337_a2001_T1018
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	birth	GO_BP_EXT	[42724]	[42729]	BMJ_2008_Nov_7_337_a2001_T717
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	preterm	GO_BP_EXT	[42741]	[42748]	BMJ_2008_Nov_7_337_a2001_T718
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	delivery	GO_BP_EXT	[42749]	[42757]	BMJ_2008_Nov_7_337_a2001_T719
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	women	NCBITAXON_EXT	[42761]	[42766]	BMJ_2008_Nov_7_337_a2001_T841
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	women	NCBITAXON_EXT	[42846]	[42851]	BMJ_2008_Nov_7_337_a2001_T842
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	women	UBERON_EXT	[42846]	[42851]	BMJ_2008_Nov_7_337_a2001_T1019
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[42926]	[42930]	BMJ_2008_Nov_7_337_a2001_T381
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	pregnancy	GO_BP_EXT	[42938]	[42947]	BMJ_2008_Nov_7_337_a2001_T720
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	physiological	GO_BP_EXT	[42961]	[42974]	BMJ_2008_Nov_7_337_a2001_T721
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	gestation	GO_BP_EXT	[43023]	[43032]	BMJ_2008_Nov_7_337_a2001_T722
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[43173]	[43177]	BMJ_2008_Nov_7_337_a2001_T382
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[43185]	[43189]	BMJ_2008_Nov_7_337_a2001_T383
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	folic acid	CHEBI_EXT	[43190]	[43200]	BMJ_2008_Nov_7_337_a2001_T384
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	micronutrient	CHEBI_EXT	[43249]	[43262]	BMJ_2008_Nov_7_337_a2001_T385
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[43337]	[43341]	BMJ_2008_Nov_7_337_a2001_T386
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	iron	CHEBI_EXT	[43374]	[43378]	BMJ_2008_Nov_7_337_a2001_T387
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	vitamin C	CHEBI_EXT	[43384]	[43393]	BMJ_2008_Nov_7_337_a2001_T388
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	micronutrient	CHEBI_EXT	[43410]	[43423]	BMJ_2008_Nov_7_337_a2001_T389
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	supplements	CHEBI_EXT	[43424]	[43435]	BMJ_2008_Nov_7_337_a2001_T390
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	iron	CHEBI_EXT	[43474]	[43478]	BMJ_2008_Nov_7_337_a2001_T391
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	iron	CHEBI_EXT	[43553]	[43557]	BMJ_2008_Nov_7_337_a2001_T392
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	response	GO_BP_EXT	[43572]	[43580]	BMJ_2008_Nov_7_337_a2001_T723
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	haemoglobin	CHEBI_EXT	[43584]	[43595]	BMJ_2008_Nov_7_337_a2001_T393
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	haemoglobin	CHEBI_EXT	[43584]	[43595]	BMJ_2008_Nov_7_337_a2001_T769
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	iron	CHEBI_EXT	[43617]	[43621]	BMJ_2008_Nov_7_337_a2001_T394
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	folic acid	CHEBI_EXT	[43622]	[43632]	BMJ_2008_Nov_7_337_a2001_T395
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	micronutrients	CHEBI_EXT	[43646]	[43660]	BMJ_2008_Nov_7_337_a2001_T396
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	neonatal	UBERON_EXT	[43693]	[43701]	BMJ_2008_Nov_7_337_a2001_T1020
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	iron	CHEBI_EXT	[43772]	[43776]	BMJ_2008_Nov_7_337_a2001_T397
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_182	[43807]	[43921]	['We observed a larger birth weight response in the multiple micronutrients group than in the iron-folic acid group.']	birth	GO_BP_EXT	[43828]	[43833]	BMJ_2008_Nov_7_337_a2001_T724
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_182	[43807]	[43921]	['We observed a larger birth weight response in the multiple micronutrients group than in the iron-folic acid group.']	response	GO_BP_EXT	[43841]	[43849]	BMJ_2008_Nov_7_337_a2001_T725
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_182	[43807]	[43921]	['We observed a larger birth weight response in the multiple micronutrients group than in the iron-folic acid group.']	micronutrients	CHEBI_EXT	[43866]	[43880]	BMJ_2008_Nov_7_337_a2001_T398
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_182	[43807]	[43921]	['We observed a larger birth weight response in the multiple micronutrients group than in the iron-folic acid group.']	iron	CHEBI_EXT	[43899]	[43903]	BMJ_2008_Nov_7_337_a2001_T399
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_182	[43807]	[43921]	['We observed a larger birth weight response in the multiple micronutrients group than in the iron-folic acid group.']	folic acid	CHEBI_EXT	[43904]	[43914]	BMJ_2008_Nov_7_337_a2001_T400
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	iron	CHEBI_EXT	[43990]	[43994]	BMJ_2008_Nov_7_337_a2001_T401
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	folic acid	CHEBI_EXT	[43995]	[44005]	BMJ_2008_Nov_7_337_a2001_T402
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	micronutrients	CHEBI_EXT	[44019]	[44033]	BMJ_2008_Nov_7_337_a2001_T403
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	birth	GO_BP_EXT	[44061]	[44066]	BMJ_2008_Nov_7_337_a2001_T726
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	micronutrients	CHEBI_EXT	[44090]	[44104]	BMJ_2008_Nov_7_337_a2001_T404
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	iron	CHEBI_EXT	[44125]	[44129]	BMJ_2008_Nov_7_337_a2001_T405
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	folic acid	CHEBI_EXT	[44130]	[44140]	BMJ_2008_Nov_7_337_a2001_T406
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	neonatal	UBERON_EXT	[44232]	[44240]	BMJ_2008_Nov_7_337_a2001_T1021
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	fetal	UBERON_EXT	[44281]	[44286]	BMJ_2008_Nov_7_337_a2001_T1022
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	growth ... development	GO_BP_EXT	[44287, 44298]	[44293, 44309]	BMJ_2008_Nov_7_337_a2001_T727
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	newborn	UBERON_EXT	[44359]	[44366]	BMJ_2008_Nov_7_337_a2001_T1023
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	infant	UBERON_EXT	[44385]	[44391]	BMJ_2008_Nov_7_337_a2001_T1024
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	growth	GO_BP_EXT	[44392]	[44398]	BMJ_2008_Nov_7_337_a2001_T728
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	immune	UBERON_EXT	[44408]	[44414]	BMJ_2008_Nov_7_337_a2001_T1025
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	immune responses	GO_BP_EXT	[44408]	[44424]	BMJ_2008_Nov_7_337_a2001_T729
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	cognitive	GO_BP_EXT	[44439]	[44448]	BMJ_2008_Nov_7_337_a2001_T730
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	micronutrient	CHEBI_EXT	[44481]	[44494]	BMJ_2008_Nov_7_337_a2001_T407
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	newborn	UBERON_EXT	[44545]	[44552]	BMJ_2008_Nov_7_337_a2001_T1026
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	infant	UBERON_EXT	[44553]	[44559]	BMJ_2008_Nov_7_337_a2001_T1027
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	birth	GO_BP_EXT	[44590]	[44595]	BMJ_2008_Nov_7_337_a2001_T731
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	birth	GO_BP_EXT	[44607]	[44612]	BMJ_2008_Nov_7_337_a2001_T732
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	gestation	GO_BP_EXT	[44650]	[44659]	BMJ_2008_Nov_7_337_a2001_T733
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	growth	GO_BP_EXT	[44688]	[44694]	BMJ_2008_Nov_7_337_a2001_T734
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	neonatal	UBERON_EXT	[44704]	[44712]	BMJ_2008_Nov_7_337_a2001_T1028
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	response	GO_BP_EXT	[44737]	[44745]	BMJ_2008_Nov_7_337_a2001_T735
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	iron	CHEBI_EXT	[44753]	[44757]	BMJ_2008_Nov_7_337_a2001_T408
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	supplements	CHEBI_EXT	[44765]	[44776]	BMJ_2008_Nov_7_337_a2001_T409
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	gestation	GO_BP_EXT	[44821]	[44830]	BMJ_2008_Nov_7_337_a2001_T736
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	delivery	GO_BP_EXT	[44858]	[44866]	BMJ_2008_Nov_7_337_a2001_T737
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	micronutrients	CHEBI_EXT	[44902]	[44916]	BMJ_2008_Nov_7_337_a2001_T410
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	iron	CHEBI_EXT	[44973]	[44977]	BMJ_2008_Nov_7_337_a2001_T411
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	folic acid	CHEBI_EXT	[44978]	[44988]	BMJ_2008_Nov_7_337_a2001_T412
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	pregnancy	GO_BP_EXT	[45004]	[45013]	BMJ_2008_Nov_7_337_a2001_T738
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	delivery	GO_BP_EXT	[45075]	[45083]	BMJ_2008_Nov_7_337_a2001_T739
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	neonatal	UBERON_EXT	[45088]	[45096]	BMJ_2008_Nov_7_337_a2001_T1029
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	deaths	GO_BP_EXT	[45097]	[45103]	BMJ_2008_Nov_7_337_a2001_T740
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	iron	CHEBI_EXT	[45125]	[45129]	BMJ_2008_Nov_7_337_a2001_T413
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	pregnancy	GO_BP_EXT	[45144]	[45153]	BMJ_2008_Nov_7_337_a2001_T741
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	iron	CHEBI_EXT	[45185]	[45189]	BMJ_2008_Nov_7_337_a2001_T414
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	micronutrient	CHEBI_EXT	[45205]	[45218]	BMJ_2008_Nov_7_337_a2001_T415
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	pregnant	GO_BP_EXT	[45235]	[45243]	BMJ_2008_Nov_7_337_a2001_T742
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	women	NCBITAXON_EXT	[45244]	[45249]	BMJ_2008_Nov_7_337_a2001_T843
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	women	UBERON_EXT	[45244]	[45249]	BMJ_2008_Nov_7_337_a2001_T1030
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	neonatal	UBERON_EXT	[45300]	[45308]	BMJ_2008_Nov_7_337_a2001_T1031
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	Neonatal	UBERON_EXT	[45357]	[45365]	BMJ_2008_Nov_7_337_a2001_T1032
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	deaths	GO_BP_EXT	[45366]	[45372]	BMJ_2008_Nov_7_337_a2001_T743
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	child	NCBITAXON_EXT	[45397]	[45402]	BMJ_2008_Nov_7_337_a2001_T844
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	child	UBERON_EXT	[45397]	[45402]	BMJ_2008_Nov_7_337_a2001_T1033
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	birth	GO_BP_EXT	[45531]	[45536]	BMJ_2008_Nov_7_337_a2001_T744
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[45631]	[45640]	BMJ_2008_Nov_7_337_a2001_T745
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	Antenatal	UBERON_EXT	[45663]	[45672]	BMJ_2008_Nov_7_337_a2001_T1034
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	iron	CHEBI_EXT	[45673]	[45677]	BMJ_2008_Nov_7_337_a2001_T416
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	folic acid	CHEBI_EXT	[45678]	[45688]	BMJ_2008_Nov_7_337_a2001_T417
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	gestation	GO_BP_EXT	[45715]	[45724]	BMJ_2008_Nov_7_337_a2001_T746
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	delivery	GO_BP_EXT	[45748]	[45756]	BMJ_2008_Nov_7_337_a2001_T747
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	neonatal	UBERON_EXT	[45814]	[45822]	BMJ_2008_Nov_7_337_a2001_T1035
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	folic acid	CHEBI_EXT	[45847]	[45857]	BMJ_2008_Nov_7_337_a2001_T418
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	Antenatal	UBERON_EXT	[45864]	[45873]	BMJ_2008_Nov_7_337_a2001_T1036
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	micronutrients	CHEBI_EXT	[45883]	[45897]	BMJ_2008_Nov_7_337_a2001_T419
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	birth	GO_BP_EXT	[45916]	[45921]	BMJ_2008_Nov_7_337_a2001_T748
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	folic acid	CHEBI_EXT	[45943]	[45953]	BMJ_2008_Nov_7_337_a2001_T420
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	neonatal	UBERON_EXT	[46023]	[46031]	BMJ_2008_Nov_7_337_a2001_T1037
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	iron	CHEBI_EXT	[46062]	[46066]	BMJ_2008_Nov_7_337_a2001_T421
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	micronutrient	CHEBI_EXT	[46082]	[46095]	BMJ_2008_Nov_7_337_a2001_T422
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	pregnant	GO_BP_EXT	[46112]	[46120]	BMJ_2008_Nov_7_337_a2001_T749
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	women	NCBITAXON_EXT	[46121]	[46126]	BMJ_2008_Nov_7_337_a2001_T845
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	women	UBERON_EXT	[46121]	[46126]	BMJ_2008_Nov_7_337_a2001_T1038
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	neonatal	UBERON_EXT	[46153]	[46161]	BMJ_2008_Nov_7_337_a2001_T1039
